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1. Introduction 
 
The founders of “Pharmaceutics” brought the science of physical chemistry to drug 
delivery, recognizing “Pharmaceutics” as the science of rationale dosage form 
development.  
The design and the production of effective, stable, uniform and safe dosage forms that 
contain exact quantities and specific qualities of active pharmaceutical ingredients (APIs) 
is the primary mission of the pharmaceutical industry. The quality of a product is strongly 
related to and influenced by its design in research and development.  
In the case of the solid dosage form a great attention has been paid, in recent years, on 
particle engineering defined as the discipline enabling the scientist to design solid dosage 
forms tailored to possess optimal physico-chemical characteristics (Pasquali et al., 2006). 
Specific characteristics of particles (size, shape, surface, crystal structure and morphology) 
are among the important factors to control technological and biopharmaceutical properties 
of drug products. In general, morphology (crystal habit) can influence the physical and 
chemical stability of solid dosage forms, a narrow size distribution is important to obtain 
content uniformity, while sphericity allows good flowability and tablettability. 
Furthermore, micronisation increases the surface area with a consequent increase of 
dissolution rate and bioavailability of the drug, thus promoting the formulation of active 
principle ingredients which may be insoluble or slightly soluble in aqueous media. Finally, 
the increase of bioavailability maximizes the efficiency of the drug and hence minimizes 
the required dosage. 
Technological and biopharmaceutical characteristics can also be improved by co-
formulation of the API with polymers. Co-formulations are used to increase (fast-release) 
or decrease (sustained release) the dissolution rate of the drug, for taste-masking, where a 
drug is co-formulated to remove or disguise an unpleasant taste, and in general to improve 
technological characteristics such as: sphericity, flowability, tabletability etc.  
Formulation of drug delivery systems implies the challenge of producing particles with 
optimal physico-chemical characteristics, especially in the case of an administration  by 
parenteral or inhalation route. For inhalation route, particles with a size less then 5 μm, 
narrow particle size distribution, appropriate aerodynamic size, shape and apparent density 
are required. Whilst is crucial to control the aerodynamic particle size, it is also important 
to control the surface properties as micronized tend to be highly charged leading to 
agglomeration. Furthermore, some techniques used to reduce particle sizes (milling, spray-
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drying) damage the crystal structure of the drug leading to total or partial amorphisation, 
which leads to the physical instability of the drug.   
Meanwhile, there is a continuous effort to develop processes pollution-free, with low 
environmental impact. Numerous pharmaceutical processes use volatile organic compound 
(VOC) as medium for preparation of drug delivery systems, but VOCs emission limit are 
being reduced in many industrialised countries, for example the European Union 
legislation came into force in 2000 (Hay et al., 2002). Furthermore, the “green” 
alternatives has become very important, especially in case of pharmaceutical industries, 
because the regulatory requirements are more and more restrictive for the residual contents 
of volatile organic compounds in the API and in the final products. A “green” solvent, 
alternative to traditional solvents, may lead both to a technical and commercial benefits.  
A relatively recent approach for obtaining pharmaceutical microparticles with desired 
physico-chemical characteristics is represented by technologies based on the supercritical 
fluids (SCF). By proper adjustment of the operating conditions as well as physical and 
chemical parameters, (pressure, temperature, drug concentration, flow and nature of 
supercritical fluid and organic solvent) materials with desired biopharmaceutical and 
technological characteristics can be generated. Advantages in the use of supercritical fluids 
technology are the high versatility, the flexibility in offering alternative processing 
approaches, the possibility to avoid or minimize the use of organic solvents and to reach 
peculiar process conditions (i.e., change in the pressure and in the rate of solvent 
evaporation) difficult to obtain with traditional processes (Pasquali et al., in press-b). In 
fact, the most discernible process parameters that differentiate the SCF technologies from 
the conventional ones are the high compressibility and diffusivity of the supercritical fluid, 
the possibility of fine tuning pressure and solvent evaporation rate.  
Great attention is given to the SCFs also in the field of polymer processing (Nalawade et 
al., 2006a). Most of the beneficial effects of SCF in the polymers processing are due to the 
possible weak interaction of CO2 with the macromolecular chains of the polymer. As 
demonstrated by some authors (Kazarian et al., 1996, Nalawade et al., 2006b, Pasquali et 
al., in press-a), CO2 is a weak Lewis acid that may interact with the basic sites in the 
polymer leading to the absorbtion of significant amount of CO2. The absorption of the gas 
results in an increase of the inter-chain distances as well as of the degree of chains-
segmental mobility causing a polymer plasticization and a decrease of the polymer 
viscosity. The property of CO2 to reduce the glass transition temperature and viscosity of 
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the polymer would be beneficial for enhancing in the processing of composite materials 
during mixing, homogenization, coating, extrusion and foaming. 
Polymer plasticization can be also induced thermally or by means of organic solvents. 
Major drawbacks of these approaches are the difficulty to process heat-sensitive materials 
and the possible presence of residues solvent in the final product. By using the SCF, there 
is no residual solvent in the material produced, in fact, being a gas at ambient condition, it 
can easily be removed from the final product. 
The application of the SFC technology in the control of physico-chemical properties of 
drug particles (Pasquali et al., 2006, Pasquali et al., in press-b) and the production of 
controlled-release drug formulations seems to have at the moment a big development, as 
reflected by the large number of patents granted in this area. 
Despite the numerous advantages in the use of SCF, it must be stated that these techniques 
are not going to replace existing and well-established techniques (solvent coating, 
granulation, spray-drying, etc.); but more likely they are going to support them.  
One of the major drawbacks of the SCF techniques presently represented by the high cost 
of the equipments. This can be mainly ascribed to the fact that the field is still young and 
the SCF technologies are not yet widespread.  
 
1.1. Supercritical fluids properties 
 
In 1822, Cagniard de la Tour first put into evidence the existence of a supercritical phase 
by observing the disappearance of two distinct gas and liquid phases into one visually 
homogeneous phase by increasing the temperature of a material in a closed glass container 
(Cagniard de LaTour, 1822).  
The first report that describes a process using the supercritical fluid as a medium for 
obtaining solid materials was published by Hannay and Hogarth: “ We have then, the 
phenomenon of a solid with no measurable gaseous pressure, dissolving in a gas. When the 
solid is precipitated by suddenly reducing the pressure, it is crystalline, and may be 
brought down as snow in the gas, or on the glass as a frost, but it is always easily 
redissolved by the gas  on increasing the pressure” (Hannay and Hogarth, 1879).  
 
A supercritical fluid can be defined as a dense non-condensable fluid.  
A fluid reaches the supercritical status when its temperature and pressure exceed the 
relevant critical temperature and pressure.  
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Figure 1: Images of the CO2 at different pressure and temperature values 
(http://www.galenotech.org/tecniche_est.htm)   
 
As it can be observed in Figure 1, below the critical point a liquid and a gas phase are 
separated by a meniscus; with an increase in temperature or pressure the meniscus begins 
to disappear. Further increase of temperature causes the gas and liquid densities to become 
similar. The meniscus is less easily observed but still evident. Once the critical temperature 
and pressure have been reached the two distinct phases (liquid and gas) are no longer 
visible. The macroscopic appearance of the SCF is a homogeneous and opalescent system 
without phase separation (single phase) because, at this point, the density of the gas and 
liquid are identical. Nevertheless, a SCF does not show a specific aggregation state; in fact 
its physico-chemical properties are intermediate between those of liquid and gas (Table 1).  
 
                                Table 1. Physico-chemical characteristics of a substance as gas, liquid and SCF. 
                                                    * standard condition (1 atm, 20 °C) 
                                                   **at critical pressure and temperature  
 
 
 
 
 
 
 
Like a gas the SCF shows a lower viscosity and higher diffusivity relative to the liquid. 
These properties facilitate mass transfer and all related phenomena, so SCFs can diffuse 
and impregnate matrices like a gas. Like a liquid, the SCF shows a density value 
appreciable for the solvation power. Most importantly, the SCF is dense but highly 
Physical state 
Density 
(g / ml) 
Viscosity 
 ( g/cm⋅s) 
Diffusivity 
(cm 2 / s) 
Gas* 10-3 10-4 10-1 
Liquid  1 10-2 10-6 
 SCF** 0.2 –0.8 10-4 10-3 
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compressible, thus, any change of pressure alters its density and consequently the solvent 
power (Brunner, 1994). The greatest change of the solvent density is attained in the 
vicinity of the solvent’s critical point, where the solvent compressibility is large, and small 
changes in pressure yield a large change in density (Figure 2). 
 
 
Figure 2. Carbon dioxide density-pressure phase diagram 
 
At the microscopic level, the opalescence observed at the critical point can be interpreted 
considering the fluctuations of the local density with a correlation length of the same order 
of magnitude than that of the visible light. The inhomogenity is the most fundamental 
concept which characterizes the supercritical status, and the density fluctuations is a 
measure of the inhomogenity in the distribution of the molecules. It has been reported that 
there is likely a local organization of molecules inside the supercritical region with areas of 
local densities for both the gas and liquid (Nishikawa and Morita, 2000). This organization 
is dynamic and these fluctuations of density allow to explain the increase of the fluid 
compressibility. Inside the schematic phase diagram of CO2 near the critical point, (Figure 
3) it is possible to identify a ridge that separates the more liquid-like and more gas-like 
regions in the supercritical region.  
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Figure 3. Schematic phase diagram of CO2 
 
The ridge corresponds to a maximum or minimum of various physical quantities of SCFs, 
which are related to the second derivates of the Gibbs free energy, such as isothermal 
compressibility, thermal conductivity, and partial molar volumes (Koga et al., 2006).    
Although these unique and complementary physical characteristics allow the development 
of efficient and versatile processes, it should be underscored that the SCF can not be 
considered as the universal “super-solvent”. 
The peculiar characteristics of SCFs lead to a rapidly grown of the field, and of 
consequence, to important industrial applications (Perrut, 2000, Perrut, 2003). Except for 
processes applied in the petrochemical industry, supercritical fluids applications are mainly 
focusing on extraction/fractionation from solid materials for food products (coffee and tea), 
food ingredients (hops, aromas, coloring agents, vitamins, and unsatured fatty acids) and 
nutraceuticals/phytopharmaceuticals (Jung and Perrut, 2001, King and Bott, 1993, Perrut 
and Reverchôn, 2000, Perrut and Subra, 1998, Poliakoff et al., 1999, Rizvi, 1994). At 
present, supercritical fluids techniques are still expanding and new applications are being 
investigated. Some of them are listed below: 
• Ceramics manufacture: preparation of a new generation of inorganic cross-flow 
membranes (Sarrade et al., 2003); 
• Reactions: synthesis of complex organic molecules (Prajapati and Gohain, 2004); 
• Preparative Scale Supercritical Fluid Chromatography: fractionation of very similar 
compounds, especially lipids; 
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• Preparation of foams (Alavi et al., 2003a, Alavi et al., 2003b) and aerogels (Fricke 
and Tillotson, 1997, Gross et al., 1998 ). Various SF-processed nano-systems or nano-
structured materials for applications mainly in the micro-electronic industry; (Perrut, 2000) 
• Polymer processing: impregnation, extraction of residues (stripping), morphological 
modifications (foams, particles, and fibers) and particle coating. 
Among the new applications of SCFs, particle engineering of pharmaceutical materials 
seems to be at the moment the area with the major development. 
 
All gases can be a SCF above specific sets of critical conditions (P,T), but it should be 
born in mind also that, for many cases, the transition to the supercritical state occurs at 
high temperatures not compatible with pharmaceutical compounds (e.g., SC water, Table 
2).  
 
Table 2: Critical parameters of selected compounds 
 
                     Tc (°C) Pc (MPa) 
 
H2O  374 22 
Xe  16.6 5.9 
SF6   45.5 3.8 
N2O  36.5 4.1 
C2H4  9.1 5.1 
CHF3  25.9 4.7 
CO2   31.3 7.4 
 
 
The critical P, T values increase with the molecular weight or intermolecular hydrogen 
bonding or polarity (Vasukumar and Bansal, 2003). Not only the mild processing 
conditions, but also safety and affordable economics are valid criteria to choose the 
supercritical fluid. For example, Xenon and SF6 (when sufficiently purified), have low 
critical values, but they are still too expensive for commercial use. Gases as N2O or ethane 
have low critical values, but can generate explosive mixtures and are therefore unsafe to 
handle. Some authors (Hillmann and Bächmann, 1995, Nakatani et al., 1989, Sako et al., 
1989) used as SCF trifluoromethane (CHF3) which is chemically inert, non-flammable, has 
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low toxicity and low critical temperature and pressure. Furthermore, CHF3 has a strong 
permanent dipole moment (1.56 D) thus it can solubilize pharmaceutical compounds. 
However, more than 98 % of  applications have been developed using carbon dioxide as 
SCF because of its low critical temperature (31,18 °C) and pressure (7.4 MPa), 
inexpensiveness, non–flammability, non-toxicity, recyclability and environmental 
benignity.  
 
1.2.  Processes using supercritical fluids 
 
There are several methods based on the supercritical fluids for particles production, which 
can be divided into four groups. 
i) Processes using supercritical fluids as solvent. The rapid expansion of a supercritical 
solution (RESS) is the process that exemplifies this first group. The supercritical fluid is 
used as crystallization solvent; in fact, with RESS the solute is first dissolved in a 
supercritical fluid, then the solution is rapidly expanded by sudden decompression, 
typically  by passing through an orifice at lower pressure.  
ii) Processes using supercritical fluids as antisolvent. In this case, the supercritical fluid 
(antisolvent) comes in contact with the solute dissolved in a suitable organic solvent. The 
crystal formation is due to the sharp decrease of the solvent power of the organic phase. 
iii) Processes using supercritical fluids to assist the spray-drying thechnique. These 
techniques are close to the classic micronization by spray-drying, where the SCFs is used 
to assist the nebulization of the solution of the compound to be process. 
iiii) Processes using supercritical fluids to precipitate molten material from gas saturated 
solution. The supercritical fluid is dissolved into a solution of a solute or into a melted 
material. Then, a rapid depressurization of the mixture, that occurs through a nozzle 
causing the particles formation.  
 
1.2.1 Processes using supercritical fluids as solvent  
 
RESS (Rapid Expansion Supercritical Solution) 
 
Nearly a century later the discovery of  Hannay and Hogarth, Krukonis first applied the 
concept of producing fine particles with a narrow size distribution using a SCF (Krukonis, 
1984). This technique was called rapid expansion of a supercritical solution (RESS). A 
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typical RESS process is carried out with an apparatus consisting of a pre-heater, a 
solubilization vessel, and a precipitator (Figure 4). 
 
 
Figure 4. Schematic representation of RESS 
 
The heated gas is pressurized and pumped into the solubilization unit (extractor), 
containing the solute. The supercritical fluid dissolves the solute; then the solution is 
rapidly expanded (decompressed) by passing through a heated nozzle at supersonic speed. 
During the rapid expansion of the supercritical solution, both density and solvent power 
decrease dramatically leading to a solute supersaturation. The solution reaches almost 
instantaneously, a highly homogeneous supersaturation with a degree of supersaturation 
often much higher than that achieved by thermal methods. The combination of large, rapid 
and uniform supersaturation is the major advantage of RESS and leads to the production of 
small particles with uniform size (Phillips and Stella, 1993) 
The parameters that influence this process can be divided into pre- and post-expansion 
conditions. The pre-expansion conditions are temperature and pressure of the vessel. These 
operative parameters influence the kinetics of the crystallization process changing the 
density of the SCF and, consequently, the pre-expansion concentration. This last depends 
also on the supercritical fluid, the nature of the solute (crystalline or amorphous, composite 
or pure), and possible addition of a cosolvent. The higher the pre-expansion concentration, 
the narrower the particle size range will be (Phillips and Stella, 1993) 
The post-expansion conditions depend on the nozzle temperature, geometry and size, 
distance and angle of impact against the surface of the jet stream (Kayrak et al., 2003) 
(Figure 5).  
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Figure 5. Schematic draw of the nozzle in the RESS process (Kayrak et al., 2003) 
 
The nozzle can be maintained at a suitable pre-expansion temperature to prevent the 
premature precipitation of the solute.  
The advantages of RESS are that it is a simple process, and relatively easy to implement on 
a small scale when a single nozzle is used. Another attractive characteristic of this process 
is its environmental benignity: it allows minimization of the use of organic solvent and the 
reuse the SCF in a continuous process. On the other hand, the main drawback, limiting the 
scaling of this process, is represented by the poor solubility of most pharmaceutical 
products in supercritical CO2. The CO2 is a non polar molecule with low molecular weight, 
scarcely able to dissolve drugs that, typically, are weak bases or acids and, therefore, show 
more or less pronounced polar characteristics. In the RESS technique, the solubility value, 
for obtaining a reasonable yield, should be in the order of 10-4 mole fraction. Otherwise, 
the low solubility can, in some instances, be overcome with appropriate tuning of the fluid 
density and/or using an adequate cosolvent. Cosolvents modify the polarity of the solvent 
phase in favour of the solute, thereby improving the solvent power. Enhancement factors  
values of 104-106 (defined as the measured solubility divided by the solubility in the SCF 
without cosolvent) are common, although even values as high as 1012 have been reported 
(Kompella and Koushik, 2001) Other limitations are poor predictive control of particle size 
and morphology along with the difficulty of scaling-up the process because of particle 
aggregation and nozzle blockage caused by cooling due to the rapid expansion of the 
supercritical solution (York, 1999). 
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RESOLV (Rapid Expansion of a Supercritical Solution into a Liquid Solvent) 
 
The solution of the drug in liquid CO2 is prepared inside a high pressure syringe pump. 
The solution is pumped into a heating unit to attain the desire temperature before the 
expansion through a laser-drilled orifice. The rapid expansion of the solution occurs into an 
aqueous medium at ambient pressure. Various water-soluble polymers could be added to 
the aqueous medium for stabilizing the nanoparticles suspension (Meziani et al., 2005). 
 
1.2.2 Precipitation using supercritical fluids as antisolvent 
 
Gallagher et al. (Gallagher et al., 1989) first proposed a SCF process alternative to RESS to 
overcome the limitation of poor solubility of most organic compounds in SC-CO2. This 
technique was first tested to micronize explosives because milling generates high local 
temperatures, while the use of CO2 as an antisolvent allowed to proceed at milder 
temperature. This method is based on the ability of a liquid to solubilize a large amounts of 
gaseous CO2. The antisolvent must show a low affinity for the solute but at least partial 
miscibility with the organic phase. The nucleation and the consequent growth of crystals 
from the solute/organic solvent/antisolvent system are governed by the diffusion of the 
antisolvent into the organic phase and the evaporation of the organic solvent into the 
antisolvent phase (Figure 6). 
 
 
Figure 6. Single droplet (solvent + solute) as the smallest unit where the crystallization occurs. G gas 
(antisolvent), D diffusion of the antisolvent into the solution, E evaporation of the organic solvent into the 
antisolvent phase 
 
The volume expansion caused by the antisolvent diffusion lowers the solubility of the 
solute due to density reduction. On the other hand, the solvent evaporation into the gas 
D 
solvent +  
solute 
E 
G
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phase increases the solute concentration. The combined phenomena lead to supersaturation, 
nucleation and particle formation (Bristow et al., 2001). 
Contributions from thermodynamics, fluid dynamics, and nucleation kinetics are necessary 
to describe the antisolvent precipitation. Mass transfer coefficient governs the rate of 
mutual transport of the SCF into the solvent phase and viceversa. The relationship that 
describes the rate of mutual transport for component (Ni) is represented by a simple 
solution of the Fick’s law,  
 
Ni = KL,SC a (Cie – C) [1] 
 
where, a is the mass transfer area,  Cie  is the saturated concentration in the respective 
supercritical (SC) or liquid (L) phase, C is the concentration in the bulk liquid or SC phase, 
and KL,SC is the overall mass transfer coefficient either in the liquid or SC phase (Bristow 
et al., 2001). 
Since crystallization is the opposite of dissolution, the diffusion theory (Brunner, 1904, 
Nernst, 1904, Noyes and Whitney, 1897) can be applied. Therefore, equation 2 holds for 
the solute mass transfer rate (Nso) over the crystal surface area, ac : 
 
Nso = Kso ac (Css – Cs) [2] 
 
here,  Css is the supersaturated concentration and  Cs is the solubility (both in the liquid 
phase), and Kso is the solute mass transfer coefficient (Figure 7). 
 
 Figure 7. Scheme of the concentration profile at the crystal-supersaturated solution interface; Cs equilibrium 
concentration, Css supersaturated concentration, h thickness of the diffusional path lenght 
Crystal surface 
Css 
Cs 
Solution 
h 
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To achieve a high supersaturation and thus particle formation level, the mass transfer rate 
has to be improved, by increasing the mass transfer area, the concentration gradient, or the 
SCF/solvent ratio.  
As far as the surfacial mass transfer is concerned, it can be increased by spraying a phase 
into the other. In this case, the nucleation of the particle depends on the efficiency of the 
droplets generation. The distribution of the droplet size has to be as homogeneous as 
possible. The Weber number (Nwe), which is the ratio between disruptive fluid dynamic 
and inertial forces and the shape maintaining interfacial forces, determines the droplet size. 
 
Nwe = σ
νρ DAA 2  [3] 
 
where Aρ  is the density of the antisolvent, 2Av  is the relative velocity, D is the jet diameter 
and σ  is the interfacial tension (Brunner, 1904). The higher the Weber number, the lower 
the droplet size and viceversa.  
Another important factor that must be considered in an antisolvent process is the efficiency 
of the mixing between the SCF and the solution. The Reynolds number (NRe) describes the 
mixing efficiency 
 
NRe = η
ρ Lvs  [4] 
 
where, ρ  is the density of the fluid, υs is the mean fluid velocity, L is the characteristic 
length (equal to the diameter if the cross-section is circular), and η is the fluid viscosity. It 
is possible to obtain a complete mixing at a high Reynolds numbers (> 10,000) that  lead to 
dry particles with little agglomeration. In this situation, the flow  is dominated by inertial 
forces, producing random eddies, vortices and other flow fluctuations (turbulent flow). At 
low Reynolds numbers, the viscous forces prevail, and the flow is characterized by smooth, 
constant fluid motion (laminar flow) (Shekunov et al., 1999). The nozzle geometry, the 
nature of the solvent and of the SCF are the main factors influencing the parameters 
described above. However, it must be underlined that the density of the antisolvent, which 
is one of the more easily tunable parameter (via temperature and/or pressure variation) in a 
SCF, can be considered the key factor of the process. 
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Since the driving force for crystallization is the supersaturation, other operative parameters, 
such as solute concentration, solvent to SCF ratio influence the characteristics of the 
product (Werling and Debenedetti, 1999).  
The antisolvent process is a batch discontinuous process; its main disadvantage is the 
difficulty to reach a complete removal of the residual solvent. The regulatory authorities 
clarified that the amount of residual solvent in the crystallized powder must not exceed 
predetermined concentrations (USP 30, 2007). For this reason, a final washing step of the 
precipitated particles with supercritical CO2 alone may be required to remove residual 
traces of organic solvents and to prevent condensation during depressurization.  
Different experimental designs of antisolvent processes are known and can be classified on 
the basis of different mixing modes between the solution and the SCF. 
 
GAS (Gaseous Anti Solvent)  
 
GAS is a batch technique which entails the gradual introduction of  CO2 inside a vessel 
filled with the solution of the solute of interest (Figure 8).  
 
 
Figure 8. Schematic representation of GAS 
 
The CO2  is pumped in from the bottom of the vessel, until the fixed pressure is reached. 
The main advantage of this technique is that, by introducing the SCF through the bottom of 
the vessel, a good mixing of solvent and antisolvent can be reached.  
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PCA (Particles by Compressed Antisolvent), SAS (Supercritical Antisolvent), ASES 
(Aerosol Solvent Extraction System) 
 
In these three arrangements CO2 (supercritical for SAS, or subcritical for PCA) is first 
pumped inside the high pressure vessel until the system reaches the fixed conditions 
(pressure and temperature) Subsequently, the organic solution is sprayed through a nozzle 
into the SCF bulk and the particles are collected on a filter at the bottom of the vessel 
(Figure 9). ASES represents a modification implying the simultaneously spraying of the 
solution and antisolvent. 
 
Figure 9. Schematic representation of PCA, SAS and ASES 
 
SEDS (Solution Enhanced Dispersion by Supercritical Fluids)  
 
SEDS is a technique developed by Hanna and York (Hanna and York, 1995). By this 
process the drug solution and the supercritical fluid are introduced simultaneously into the 
particle formation vessel through the mixing chamber of a co-axial nozzle (Figure 10 and 
11). 
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Figure 10. Schematic representation of SEDS (Byrappab et al., in press) 
 
The geometry of the nozzle allows to work at high Reynolds numbers (good mixing) and at 
low Weber number (small droplet size) by increasing the velocity of the fluid. Moreover, 
the use of a mixing chamber favors a higher mixing surface area that leads to a increase of 
the mass transfer (rate of mutual transport Ni in eq. 1). The high mass transfer causes a fast 
nucleation rate and the production of particles of small size with little agglomeration 
(Palakodaty and York, 1999). 
SEDS has been further developed to process water soluble compounds (e.g. peptides and 
proteins) by using  a co-axial three-component nozzle (Figure 11). The organic solvent, the 
SCF, and the aqueous solution, as separate streams, are introduced by means of the nozzle 
inside the vessel. This arrangement helps in overcoming problems associated with limited 
solubility of water in supercritical CO2 (Moshashaee et al., 2003). 
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Figure 11. Schematic representation of coaxial two and three fluid nozzle 
 
All these characteristics make SEDS a highly controlled, reproducible technique compared 
to other antisolvent-based SCF processes. Furthermore, SEDS process proved to be 
suitable for scaling up and manufacturing according to GMP requirements (York et al., 
1998). 
 
1.2.3 CO2 -Assisted Spray-Drying 
 
These techniques are aerosolization based methods where the supercritical CO2 is used to 
assist the nebulization of the solution of the compound to be processed. The mechanism of 
the process is close to classic micronization by spray-drying: the SCF and the solution are 
intimately mixed and sprayed in a drying atmosphere. Claimed advantages of this process 
are: the minimal decomposition of thermally labile drugs, the absence of a high pressure 
vessel, and the small size of produced particles (below 3 µm in diameter) (Charbit et al., 
2004). 
 
CAN-BD (Carbon dioxide Assisted Nebulization with a Bubble Dryer®) 
 
This process (Sievers and Karst, 2000) is particularly useful for substrates that are 
significantly soluble in water. Three steps are involved in the method. The drug is 
dissolved or suspended in water or alcohol (or both), and mixed intimately with near-
critical or supercritical CO2 by pumping both fluids through a near zero volume tee to 
generate an emulsion. The carbon dioxide does not solubilize the compound, but it is 
soluble in water. The emulsion expands through a flow restrictor into a drying chamber at 
Introduction 
 18
atmospheric pressure to generate aerosols of microbubbles and microdroplets that are dried 
by a flux of warm nitrogen (Figure 12). 
 
 
 
Figure 12. Schematic representation of CAN-BD 
 
SAA (Supercritical Fluid-Assisted Atomization)  
 
In this process (Reverchôn, 2002) supercritical CO2 and a solution (in water or organic 
solvent) are mixed and sprayed into a vessel loaded with stainless steel perforated saddles 
that assures a large contact surface between liquid solution and the SCF, at conditions near 
the atmospheric pressure under a flow of hot N2 (Figure 13).  
 
 
 
Figure 13. Schematic representation of SAA 
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The main differences between CAN-BD and SAA processes are the region where the 
mixing is achieved and the extent of solubilization of SC-CO2 in the liquid solution where 
the solute is dissolved.  
 
1.2.4 Precipitation from gas saturated solutions  
 
These processes use the supercritical fluids to obtain a molten material or a ternary mixture 
solute-solvent-compressed gas that are depressurized by rapid reduction of the system to 
atmospheric pressure in an expansion chamber. PGSS is the method that exemplifies this 
group. 
 
PGSS (Particle formation from Gas-Saturated Solutions) 
 
In the PGSS, the compressed gas (super- or sub-critical) is dissolved into a solution of a 
solute or into a melted material. The gas-saturated solution presents a low viscosity due to 
an increase in free volume. Moreover, the interfacial tension between gas and the liquid 
phase is lowered as the surface tension of the gas in the supercritical state is near zero. The 
solution is then expanded over a nozzle from  a supercritical status to ambient pressure. It 
causes a supersaturation of the gas and an intense expansion of the nucleated gas bubbles 
leading to explosion of the molten material into fine particles (Graser and Wickenhaeuser, 
1982) (Figure 14). 
 
 
 
Figure 14. Schematic representation of PGSS 
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The advantages of this technique are numerous. The pressure used is lower than that used 
with RESS, the required amount of gas is smaller, no additional solvent is necessary, so no 
residual solvent traces can be found in the final product, it can work in continuous mode, 
while the antisolvent technique required a wash-out step to remove the solvent traces. 
Furthermore, because of the high solubility of the compressed gas, a good process yield 
can be obtained. An interesting case is represented by the use of the PGSS technique to 
process the polymers. It is well known that compressed CO2 can act as a plasticizer and can 
decrease the melting point and/or glass transition of some polymers, (Kazarian, 2000, 
Kazarian et al., 2002, Pasquali et al., in press-c) so in this case, it is possible to use PGSS 
to load active substances on this melted polymer that form composite microspheres after 
decompression. The concept is simple and the substances both polymer and drug do not 
have to be soluble in the CO2. The main drawbacks of this technique are the poor control 
of the particle size that can, in some cases, leads to a broad particle size distribution, 
moreover the high temperature that can be required to melt some polymers may damage 
thermolabile compounds. Anyway, the balance between advantages and drawbacks is 
positive, and the technique is promising, several plants are running with capacities of some 
hundred kilograms per hour (Natex, Austria, Thar Technologies, USA, Uhde HPT, 
Germany). 
 
DELOS (Depressurization of an Expanded Liquid Organic Solution) 
 
In the DELOS technique, the compressed gas acts as a cosolvent. In fact the CO2 expands 
in an autoclave where a organic solution of the solute that has to be micronized is dissolved. 
Then the ternary mixture solute-solvent-compressed gas is depressurized by rapid 
reduction of the system pressure to atmospheric pressure in an expansion chamber 
(Ventosa et al., 2001, Ventosa et al., 2003) (Figura 15). 
 
Introduction 
 21
 
 
Figure 15. Scheme of the equipment used for DELOS experiments. P: pump; S: heat exchanger; V: valve; F: 
filter; R: high-pressure vessel; RC: recycling collector. 
 
CPCSP (Continuous Powder Coating Spraying Process) 
 
The CPCSP was proposed by Weidner et al., as an alternative technique for powder 
coating based on the PGSS (Weidner et al., 2001). In the CPCSP, the main components 
(binder and hardner) are melted in separated vessels to avoid a premature reaction of the 
polymers. The molten polymer are fed to a static mixer, here, the melts are homogenised 
with compressed carbon dioxide under pressure up to 220 bar. In the static mixtures, the 
three flows are not only intensively mixed, but a part of compressed gas dissolves in the 
polymer mixture. Then, the solution formed in the mixer expands via a nozzle to a spray 
tower.  
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A qualitative technological assessment of the different supercritical fluids based techniques 
is reported in the table 3. 
 
Table 3. Technological features of different supercritical fluids based techniques 
 
                                                      RESS              GAS/SAS/PCA               PGSS 
 
 Process                                  Discontinuous      Semicontinuous          Continuous 
 Gas demand                                High                       Medium                      Low 
 Pressure                                      High                 Low to  medium      Low to medium 
 Solvent                                        None                         Yes                         None 
 Volume of pressurized               Large               Medium to large              Small 
 equipment 
 Separation gas/solid                  Difficult                     Easy                         Easy 
 Separation gas/solvent            Not required               Difficult               Not required 
  
 
1.3 Phase behaviour 
 
When supercritical fluids based processes are used, it is important to take into account both 
the solid-fluid phase behaviour (solubility) and liquid-fluid phase behaviour (miscibility) to 
understand and be able to govern the process.  
For a full understanding of the phase equilibria for mixtures, it is important to consider the 
geometric constraints on their topology imposed by the phase rule: 
 
f = c-p+2 [5] 
 
where f is the degree of freedom, c the number of components, and p the number of phases. 
This equation (Gibbs’s phases rule) provides the number of independent variables that 
must be set in a equilibrium system. For example, for a two-phase binary mixture the 
regions of the equilibrium of the phases can be obtained either by experiment or 
calculation if the temperature and pressure are fixed. In a two-phase ternary mixture, one 
more variable, usually the overall mixture composition, must also be fixed. 
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  1.3.1 Unitary system (one component) 
 
A substance can exists in three different states: solid, liquid and gas depending on the two 
variables temperature (T) and pressure (p), as shown in Figure 3.  
Equilibrium between different phases is along the saturation curves and the three phases 
co-exist in equilibrium at the triple point. The evaporation curve (equilibrium between 
liquid and vapour phases) ends at the critical point.  
 
1.3.2 Binary system (two components) 
  
Liquid-vapour/SCF  
 
In the case of the binary system, the phase boundary can be represented on a T-x 
(temperature plotted against the mole fraction of the mixture at a constant pressure) or P-x 
diagram (pressure plotted against the mole fraction of the mixture at a constant 
temperature), then the locus of the critical points are represented on a P-T space. 
In Figure 16 a P-x diagram of  CO2 and ethanol at 70 °C is reported. The phase diagram  
was calculated using the PE-2000 software developed by the Technische Universität 
Hamburg-Harburg (Germany). The program was developed to model phase equilibria with 
a variety of equations of state. In particular for this diagram, the binary systems was 
calculated with the Peng-Robinson Equation of State (PR-EOS) using quadratic mixing 
rules. The binary interaction coefficients (kij) and critical parameters (Tc, pc, ω) for the 
pure components are taken from the literature. 
CO2 mole fraction
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Figure 16. P-x diagram of ethanol and CO2 at 70 °C 
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At low pressures the mixture only shows a homogeneous vapour phase. With pressure 
increase the mixture exhibits a dew point (at this point the liquid phase shrunk to an 
infinitely small droplet which is in equilibrium with a vapour phase). With a further 
pressure increase, a region where both the liquid and gas phase are present is reached. The 
composition of the vapour and liquid phase can be obtained by the length of the tieline 
(virtual connections between co-existing phases). The increase of the pressure leads, 
contrary to the case of a pure component system, not only to a volume change, but also 
system composition. At the composition lower than xc, with a further pressure increase, the 
mixture crosses first the bubble point curve (at the bubble point the vapour phase shrunk to 
an infinitely small bubble which is in equilibrium with a liquid phase) and then it reaches a 
single homogeneous liquid phase. At the composition xc the mixture does not cross the 
bubble point, but it reaches the critical point. Above Pc at that temperature (70 °C) all 
mixtures are supercritical (homogeneous region where ethanol and CO2 are completely 
miscible). Note that the critical point in a binary mixture is always at the maximum of the 
bimodal curve. Furthermore, the critical point is the point where dew and bubble curve 
meet; therefore the critical point is a dew and a bubble point at the same time. At 
compositions higher then xc the mixtures crosses the dew point curve twice with increasing 
pressure. It appears that the mixture is vaporizing again with increasing pressure. This 
phenomenon is called retrograde condensation. 
Another way to plot the binary phase equilibria is a T-x diagram. In this case, the change in 
temperature are plotted against the composition at a constant pressure. The resulting 
diagrams are usually very similar to the corresponding P-x diagrams, but appear to be 
upside down. 
A third way to represent fluid phase equilibria is the P-T diagram at constant composition. 
Van Konynenberg and Scott (van Konynenburg and Scott, 1980) had grouped the possible 
phase diagrams of liquid-fluid phase behaviour in  five major schematic classes which are 
represented in Figure 17. 
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Figure 17. Phase Behaviour Classification for Binary Mixtures according to Van Konynenburg and Scott  
 
The simplest binary mixture is the Type 1. The dark lines represent the vapour-liquid line 
of the pure components that terminate in the critical point (C1 and C2), while the critical 
curve runs continuously from the critical point of the more volatile component (C1) to that 
of the less volatile component (C2). Above the critical line the fluids are completely 
miscible. Type II behaviour is similar to Type I with an additional liquid-liquid critical line 
that commences at low temperatures rising steeply to high pressures from an Upper 
Critical End Point (UCEP). At this point, the liquid and gaseous phases of one component 
become identical critical in the presence of the liquid phase of the second component 
(liquid-liquid-vapour three-phase line). This indicates that, at low temperature, an 
immiscibility region between fluid and liquid is present. 
Type V fluid phase behaviour is characterised by two critical lines. The critical line from 
the component with the lower critical temperature terminates in an Upper Critical End 
Point (UCEP) whereas the other critical line ends in a Lower Critical End Point (LCEP). 
At temperatures between LCEP and UCEP three phases co-exist (liquid 1 + liquid 2 + 
vapour), but above the UCEP the fluids become completely miscible mimicking Type I 
behaviour, although with significantly higher mixture critical pressures than Type I 
systems. 
The difference between Type IV and Type V is identical to Type I and Type II. In Type IV 
a liquid-liquid critical line commences at low temperatures from an Upper Critical End 
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Point (UCEP) and rises steeply to high pressures, leading to similar operating restrictions 
as Type II.  
In Type III phase behaviour, the vapour-liquid critical line commencing from the critical 
point of the component with the higher critical temperature only extends partly to the 
critical point of the other component before rising to high pressures. Furthermore, this 
critical locus displays a continuous transition between vapour-liquid and liquid-liquid 
equilibrium. The vapour-liquid line commencing from the critical point of the component 
with the lower critical temperature ends again in an UCEP. Fluids that show this kind of 
phase behaviour are completely immiscible with solvents.  
The P-T projection are useful for a rationale design of those processes that use the SCF as 
antisolvent.  Potential antisolvents can be classified into three categories according to their 
phase behaviour with solvents: 
• Category I (Type I or Type II fluid phase behaviour) 
CO2, N2O, CHF3, CH2F2, HFAs, CnH2n (4<n<12), CnH2+n (4<n<12), etc. 
• Category II (Type V or Type IV fluid phase behaviour) 
CnH2n (1<n<5), CnH2+n (1<n<5), Xe, etc. 
• Category III (Type III fluid phase behaviour) 
He, Ar, N2, H2, CO, SF6, CH4, etc. 
Fluids belonging to category I do not introduce limitations to the process, and are probably 
the least potent antisolvents. Fluids of category II are non-polar and therefore good 
antisolvent for solids. However they have the restriction on the antisolvent process of a 
limited range of operating temperature and pressure. Fluids of category III are immiscible 
with solvents and therefore are also good antisolvent for solids, but the immiscibility 
creates processing problems that might be difficult to overcome (The solvent can not to be 
extracted from the processed material). 
It has to be remembered that it is possible to represent the whole P-T-x space in three 
dimensional diagram. But, usually binary phase diagrams are not represented in this way 
for two reasons: normally there are not enough data available to support the graph, and 
these diagrams tend to be very complicated. Anyway, it is possible to derive P-x and T-x 
projections of the mixture from the P-T diagram. 
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Solid-fluid  
 
As stated before, unlike gases at low pressure, supercritical fluids show a remarkable 
solvent power for the solids. As an example, Figure 18 shows the solubility changes of 
nifedipine in supercritical carbon dioxide as function of the pressure (Knez et al., 1995). 
The solubility decreases with increasing temperatures up to pressures below the cross over 
region, which is about 220 bar for this system, and then increases. This is explained taking 
into account two different aspects: an increase of the temperature leads to a increase of 
molecular mobility and so at higher solubility, but on the other hand, an increase in 
temperature decreases the CO2 density and therefore its solvent power. At low pressure a 
decreasing of the solubility with the increase of temperature, due to the density change, is 
observed, while above the cross over pressure the kinetic aspects become more important.   
 
 
 
Figure 18. Solubility of nifedipine in the supercritical CO2 (Knez et al., 1995) 
  
A schematic diagram for a SCF and solid system is represented in Figure 19, where the P-
T diagram is reported with the P-x sections at three different temperatures. 
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Figure 19. Representative diagram for a SCF+solid system 
 
The diagram generalizes the phase behaviour for systems in which the melting point of the 
solid is significantly higher then the critical temperature of the fluids. This diagram 
represents a system where the solid and the SFC are very dissimilar in molecular size, 
polarity, structure etc, namely when the SFC is not very soluble in the molten solute.   
The critical curve shows two branches. One branch runs in the P-T projection from the 
critical point of the more volatile component to a point of intersection with a three-phase 
curve S2LG which is called Lower Critical End Point (LCEP). The second branch of the 
critical curve runs from a point of intersection with a second branch of the S2LG (Upper 
Critical End Point, UCEP) and the critical point of the less volatile component. The three 
phase line S2LG starts in the triple point of the pure less volatile component. From the 
same point commences also a line that rises steeply to high pressures; this represents the 
liquid-solid line of the pure component.  
In the same Figure also a P-x sections at three different temperature are reported. At 
temperature TA, above the critical temperature of the more volatile component and below 
the temperature of the LCEP, a two phase region S2G is separated from a S2L region, a 
homogeneous liquid region and a LG region by three-phase equilibrium S2LG. 
Furthermore the LG region ends at high pressure in a L=G critical point. 
At temperature TB the LG region disappears and the S2G region and S2L region merge into 
one solid-fluid two phases region, which exhibits a horizontal tangent at the UCEP. This 
results in a sharp increase of the solubility of the solid in SCF. 
For the temperature TC between the UCEP and the triple point of the less volatile 
component, the P-x projection is given in the same Figure.  
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As underlined before, for this type of binary mixtures, the melting point of the solid is 
higher than the critical temperature of the SCF. Sometimes, in the presence of SCF, the 
melting point of the solid decreases with the increase of pressure. The reason of this 
depression is that, as the pressure increases, more and more as the gas dissolves into the 
solid (usually polymers) decreasing its melting point. In this case the phase diagram 
changes in shape and the right side branch of the diagram becomes close to the branch 
referred to the SCF critical line (Figure 20 a,b,c). In Figure 20 a, it is possible to note that 
the three phase curve L2L1G ends at low temperature in a quadruple point SL2L1G where 
four phases coexist. In the quadruple point three other three-phase curves terminate. The 
SL2L1 curve runs steeply to high pressure and ends in the UCEP where this curve intersects 
the critical curve. The SL2G curve runs to the triple point of the less volatile pure 
component and the SL1G curve runs to lower temperature. When the melting point of the 
less volatile component increases (e.g. in the case of the polymer with higher molecular 
weight) the melting curve of the solid shifts to higher temperature; and also the quadruple 
point shifts to higher temperature (b) and eventually coincides with the LCEP of the more 
volatile component (c). 
 
 
 
Figure 20. P-T diagrams for SCF+solid system when the SFC decreases the melting point of the solid 
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1.3.3 Ternary system (three components) 
 
A two phase ternary system has three degrees of freedom and it is usually represented in 
so-called Gibbs-triangles, where compositions is plotted at constant pressure and 
temperature. 
A typical three component system of CO2-methanol-water is drawn in Figure 21.   
 
 
 
Figure 21. Gibbs-triangle for an arbitrary ternary mixture 
 
The corners of a Gibbs-triangles represent the pure components, the edges the three binary 
systems (H2O-CO2, CO2-CH3OH, CH3OH-H2O), so any ternary mixture lies inside the 
borders of the triangle. The binodal curve (defined as the line which envelopes the region 
where liquid and vapour phases are present) is large indicating a large region of the 
immiscibility in this ternary system. The bottom of the triangle represents the binary 
system CO2-H2O, it is possible to see that only a small amount of either component is 
miscible with the other, while CH3OH and water and CH3OH and CO2 are miscible in all 
proportions. The tielines inside the binodal curve are not parallel to each other as for the 
binary system (Figure 16), and consequently, the critical point does not lie at any extreme 
point. Anyway, also in this case, the critical point is the point where dew and bubble 
curves meet each other, here, at fixed temperature, pressure and composition the three 
fluids are completely miscible. The non-parallelity of the tielines offers good possibility 
for the antisolvent process because only changing the flow ratios of the three fluid 
components, and without changing temperature and pressure it is possible to influence the 
obtained product. 
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1.4 Polymers processing using SC-CO2 
 
SC-CO2 is used in the area of polymer processing such as polymer modification, blending, 
foaming, and formation of polymer composites due to its unique properties. CO2 is able to 
plasticize many polymers owing to its capability to solubilize into them. This property 
causes an increase of chain mobility resulting in a decrease either of the glass transition 
temperature, in the case of amorphous polymers, or of melting point, in the case of 
semicrystalline polymers. Both in the rubbery or in the liquid state the polymer can be 
easily manipulated.  
A peculiar characteristic is that CO2 is a “temporary” plasticizer, CO2 is a gas under 
standard conditions so it is easily removed from the final product at the end of the process. 
Furthermore, for the intrinsic properties of the CO2, the processing of polymeric material is 
possible at mild operative conditions and the enhancement of the solute diffusion is 
possible by changing the process parameters. 
 
1.4.1 Polymer-CO2 phase behaviour (Liquid-Liquid phase behaviour) 
 
In Figure 22, the T-x, phase diagrams typical of an amorphous and monodisperse polymer-
CO2 system at three different pressure are reported.  
 
                  
 
Figure 22. T-x phase diagram typical of an amorphous and monodisperse polymer-CO2 system 
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The T-x sections of the L-L phase equilibria indicate the miscibility region of the polymer-
CO2 system, and, on the basis of different pressure, they may show upper critical, lower 
critical or hourglass-type demixing behaviour. 
In particular, at elevated pressure (P1) the section shows a LL miscibility gap in 
continuous with a maximum that represents the upper critical solution temperature (UCST); 
at intermediate pressure (P2) the miscibility gap becomes discontinuous with a maximum 
at UCST and a minimum called lower critical solution temperature (LCST); at pressure 
lower than critical pressure (P3) the miscibility gap becomes an hourglass-shaped without 
the critical point. The absence of the critical point underlines that in this case the system is 
immiscible at all temperatures within a limited concentration range (Folie and Radosz, 
1995).  
It has to be underlined that the reported diagrams are idealised, because, in the real system, 
the curve is highly asymmetric with the maximum shifted toward the CO2-rich phase. 
Furthermore, for the polydispersity of polymers, the UCST does not coincide with the 
maximum of the phase boundary, but it is shifted to higher polymer concentrations (Folie 
and Radosz, 1995). 
 
1.4.2 Pressure Induced Phase Separation (PIPS) 
 
In polymer processes based on SCF such as blending, formation of polymer composites 
without the use of organic solvents, extrusion, etc., the concentration of CO2 into the 
polymer might be kept below the saturation limit to avoid the phase separation and to work 
in a homogeneous phase. (Nalawade et al., 2006a). If the homogeneous polymer solution is 
necessary condition for the process, the pressure reduction is an integral step in the 
recovery of the end product; for this reason, there is a great interest in the study of how a 
homogeneous polymer solution may undergo phase separation as a result of a change in 
pressure (Zhuang and Kiran, 1998).   
In Figure 23, a more detailed schematic representation of the L-L phase behaviour is 
reported to explain the phenomenon of PIPS.  
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Figure 23. Schematic representation of pressure-induced phase separation in the pressure-composition phase 
diagram at fixed temperature, modified from (Palakodaty and York, 1999)  
 
The phase diagram shows the binodal curve which, as stated before, is defined as the line 
which divides the stable one phase region from the region in which two phase coexists in 
equilibrium, and the spinodal curve, which divides the two phases region into metastable 
and unstable portions. The region between the spinodal and binodal curves is the 
metastable region. 
If the system is at pressure higher than P1, is in a stable one phase region (above the 
critical point of the mixture), then, by decreasing the pressure, the system goes into two 
phases region at a pressure P2. As indicated in Figure 23, three different pressure reduction 
paths are possible (AB, EF, CD) for solutions at three different polymer concentrations, all 
starting at an initial pressure P1 and ending at a final pressure P2. The reduction in pressure 
creates a new phase formation that proceeds in two different paths (AB=CD) and leads to a 
different microscopic separation mechanism: i) nucleation and growth mechanism in the 
case of paths AB and CD (when metastable regions are entered) and ii) spinodal 
decomposition mechanism in the case of EF path (the unstable region is entered).  
In the case of nucleation and growth mechanism, the system is brought into the metastable 
region and so energy-intensive demixing occurs, consequently, the nuclei of the new phase 
form and grow into dispersed droplets in a continuous polymer-rich phase.  
In the case of the spinodal decomposition mechanism, the system is brought into 
thermodynamically unstable region and the system demixes spontaneously, forming two 
cocontinuous phases.  
Spinodal curve 
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The spinodal decomposition mechanism can occur also in the case of paths AB and CD 
when the pressure is rapidly decrease and therefore, the system goes quickly in the 
unstable region.  
The different mechanisms of the phase separation, as well as the kinetic are very important 
parameters because they can lead to final product with different morphologies, ranging 
from powders, to porous structures of different size and distributions (Zhuang and Kiran, 
1998). 
Interesting experimental works about the kinetics of PIPS in solutions of polymer and gas 
at high pressure using time- and angle-resolved light scattering were carried out by Kiran 
and co-workers (Liu and Kiran, 1999, Xiong and Kiran, 2000, Zhuang and Kiran, 1998).  
 
1.4.3 Solubility of CO2 in polymers and viceversa 
 
The solubility data of CO2 into polymer and polymer in SC-CO2 at various temperatures 
and pressures provide a very useful criteria to determine the operative conditions for all 
type of polymer processing.  
The solubility of CO2 is largely based on its ability to weakly interact with functional 
groups present along the molecular chains of the polymers. The CO2 molecule can be seen 
as a weak Lewis acid that can interact with the basic sites of the polymer; this can be 
considered the main contributor to its solubility. The evidence of this interaction was 
obtained spectroscopically by studying interactions between CO2 and polymers containing 
basic functional groups (carbonyl group or phenyl rings) (Kazarian et al., 1996).  
 
In the last decade, many experimental methods have been applied to investigate the 
solubility of CO2 in polymers at elevated pressure. The most commonly used are: phase 
separation method, pressure decay method, gravimetric method, chromatographic method 
and spectroscopic method. 
 
In the phase separation method, a molten polymer is exposed to the CO2 at desired 
pressure in an autoclave. After reaching the polymer/CO2 equilibrium system (typically 
few hours), samples are taken from the two phases: a polymer-rich and a CO2-rich phase. 
The amount of CO2 in the polymer-rich phase is determined with a flowmeter (Weidner et 
al., 1997), or by measuring the volume of CO2 corresponding to the displacement of water 
level in an inverted graduated tube which is immersed in CO2 saturated water (Daneshvar 
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and Gulari, 1989a). This method is mainly applicable to low viscosity polymers where 
mixing and sampling are relatively easy. However, this method can be criticized with 
respect to the suitability and correctness of the sampling procedure. 
 
In the pressure decay method, CO2 and polymer are placed in a closed autoclave at a fixed 
pressure and temperature. The sorption of CO2 into the polymer causes a reduction in 
pressure until the equilibrium of the system is reached. The initial pressure and temperature 
values, the volume of the system (without polymer), and the volume occupied by the 
polymer are used to calculate the amount of gas present initially. The values of temperature 
and pressure after equilibration and the volume occupied by the polymer are used to 
calculate the amount of free CO2 present. The difference between the initial and the final 
amounts of CO2 gives the amount of CO2 in the polymer (Morel and Paul, 1982). Suitable 
equations of state have to be used to calculate the density of the fluid phase. Furthermore, 
the swelling of the polymer must to be taken in account, but it can not be measured by 
these techniques. The Sanchez-Lacombe equation of state is generally used to predict the 
swelling of the polymer. 
 
Another experimental technique has been proposed to measure in-situ the amount of gas 
dissolved into polymer: the gravimetric method. By this method, the weight difference 
between the CO2-free and the CO2-sorbed polymer is used to calculate the solubility. The 
simplest approach is based on the use of a quartz spring method, originally adopted by 
Wissinger and Paulaitis. In this technique, the amount of gas absorbed is evaluated from 
the length extension of the quartz spring (where the sample was suspended), provided that 
its elastic constant k is known (Wissinger and Paulaitis, 1987). Also with this technique, 
the density of the CO2 at the operative pressure and temperature, and the swelling of the 
polymer have to be known.   
A substantially similar approach is based on the use of an electro- or microbalance to 
perform the weighting of the polymer sample directly in the dense fluid atmosphere 
(Kamiya et al., 1986). 
An improvement of the gravimetric technique is the magnetic suspension balance 
developed by Kleinrahm and Wagner. By using this approach, the measuring strength is 
transmitted without contact by a magnetic coupling from the pressurized chamber, 
containing the polymer sample, to the microbalance (Kleinrahm and Wagner, 1986). The 
microbalance can be located outside the high-pressure chamber, under standard conditions.  
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The chromatographic method is another method used to determine the solubility of CO2 in 
the polymers. The solubility measurements are carried out with a very thin film of polymer 
(few micrometers) as a stationary phase and CO2 as mobile phase. The measurement of the 
specific retention volume of a tracer determines the CO2 solubility  (Parcher, 1982).  
More recently also a gas chromatographic method was used to measure sorption of dense 
gases  into polymers (Galia et al., 2006). 
 
The polymer swelling in the solubility calculation is very important, therefore an 
experimental set-up capable to measure in situ, the swelling and the solubility at the same 
time is sought.  
Kazarian et al. pioneered the use of the FTIR spectroscopy to measure in-situ the solubility 
and swelling of the polymer under SCF.  
These authors combined a FT-IR apparatus with a high-pressure unit putting into evidence 
the interactions, at molecular level, of a series of polymers with SC-CO2. This apparatus 
can be considered a powerful tool to study the interactions of the polymeric materials with 
pressurized CO2, and to simultaneously determine the solubility and the swelling under 
SCF, by measuring the intensity of the relevant IR bands, directly in-situ, without the need 
of sampling the system (Kazarian, 2002). 
 
Data about the solubility of CO2 in the polymers are available in the literature, while a very 
few data on the solubility of polymer in CO2 are reported, likely because the solubility 
concentration of the polymers, especially the solid one, in the pressurized gas is very low, 
so very difficult to quantify. Often, to study the phase behaviour of the polymer/CO2 
system, the supercritical phase (CO2-rich) can be assumed to remain pure and only the 
polymer-rich phase is sampled.  
Noteworthy, the accurate quantification of the CO2 concentration in the polymer and of the 
polymer in the SC-CO2 represents still a challenging issue. 
 
1.4.4 Polymer plasticization 
 
The interaction between CO2 and the polymer reduces the interchain polymer bonds; this 
results in enhanced segmental mobility of the polymer and a consequent decrease of its 
glass transition or melting point. The extent of the glass transition or melting point 
depression depends on the amount of CO2 dissolved in the polymer. 
Introduction 
 37
In the rubbery or liquid state the polymer can be used as coating agent, to produce foams, 
or to incorporate drugs giving rise to a molecular dispersion that can be extruded or 
sprayed at lower pressure to obtain drug loaded microparticles. 
The polymer plasticization is accompanied by change in the mechanical and physical 
properties such as swelling foaming, crystallization and viscosity or density reduction (Bae, 
1996, Funami et al., 2007, Guadagno and Kazarian, 2004, Kazarian, 2000).  
The knowledge of this phenomena is crucial for processing development. For example, in 
the case of spraying or extrusion, where the particles are formed by forcing molten 
polymers through an orifice, it is easy to understand that characteristics such as density, or 
viscosity etc. influence the  texturisation of the material and so they are key parameters of 
the process.  
The reduction of the viscosity of the polymer bulk is associated with plasticization, as it 
was demonstrated by Bae, who studied the viscosity reduction of polymer melts by 
dynamic light scattering technique (Bae, 1996). This reduction is due to an increase in free-
volume of the polymer (swelling), steaming from CO2 absorption. The viscosity is reduced 
on the basis of the different operative conditions; therefore, the processing temperature and 
pressure need to be optimised to obtain a desired viscosity reduction. This provides a route 
to process, even at low temperature, high molecular weight polymers. 
Another important consequence of the CO2 absorption and plasticization is the possibility 
to obtain foamed material, in fact, high-pressure CO2 offers an attractive alternative to 
traditional blowing agents. The foams are defined as a porous structure formed by non-
connected (closed) cells of about 10 μm or less in diameter and cell density larger than 109 
cells/cm3 (Baldwin et al., 1996). The foam material serves as an important tool in the 
preparation of sponge scaffolds used for tissue engineering. The method to produce foams 
and porous structure concerns the saturation of the polymer with SC-CO2 at constant 
temperature and pressure, then the system is brought to the supersaturated state either by 
reducing pressure or by increasing temperature. These last creates a phase separation 
resulting in the nucleation and growth of pores.  
The plasticization and swelling effect of CO2 dissolved in the polymer can accelerate the 
diffusion of additives into the matrix. In fact, if the polymer is in the molten state, it can 
incorporate or solubilize drugs, and after depressurization, it would be possible to obtain 
microparticulate drug delivery systems. Another way to obtain microparticulate drug 
delivery systems is by impregnation. The impregnation mechanism, upon which the solute 
diffuses into the polymer matrix, may occurs via deposition or portioning. In the case of 
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deposition, the drug is soluble in CO2, and it can be carried into the matrix and precipitated 
during depressurization. Partitioning occurs when the affinity of the solute dissolved in the 
CO2 stream is higher for the matrix then for the SCF. A favourable partition coefficient 
results in a successful loading.  
A thorough understanding of the mutual solubility and behaviour of the SCF/compound 
system is the necessary prerequisite to set-up pharmaceutical processes dealing with 
polymer in the molten state. By the knowledge of the system properties and the 
manipulation of the operative conditions, it is in principle possible to achieve the process 
control to obtain materials with tailor made properties.  
 
1.5 Polyethylene glycols (PEGs) 
 
Polyethylene glycols are stable hydrophilic polymers with general formula 
HOCH2(CH2OCH2)nCH2OH; where n represents the average number of oxyethylene 
groups. Synonyms of PEG are: Carbovax, Macrogol, Breox PEG, Hodag PEG, and Lutrol 
E.  
These polymers are manufactured by a reaction of ethylene oxide and water under pressure 
in the presence of a catalyst. PEGs comprise a class of compounds varying in molecular 
weights between 200 and over 10000 (Table 4). At standard condition, PEGs up to molar 
mass 600 Da are liquid, while those with higher molar masses are solid (Kibbe, 2000).  
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Table 4. Structural formula and molecular weight of typical polyethylene glycol polymers 
 
 
Grade 
 
n 
 Average molecular 
weight 
PEG 200 4.2 190-210 
PEG 300 6.4 285-315 
PEG 400 8.7 380-420 
PEG 600 13.2 500-600 
PEG 900 15.3 855-900 
PEG 1000 22.3 900-1000 
PEG 1450 32.5 1100-1500 
PEG 1540 28.0-36.0 1300-1600 
PEG 2000 40.0-50.0 1800-2200 
PEG 3000 60.0-75.0 2700-3300 
PEG 3350 75.7 3000-3700 
PEG 4000 69.0-84.0 3000-4800 
PEG 4600 104.1 4400-4800 
PEG 8000 181.4 7000-9000 
 
 
Due to their biocompatibility (Fruijtier-Pölloth, 2005) they are widely used in cosmetics 
and in pharmaceutical formulations including parenteral, topical, ophthalmic, oral and 
rectal preparation.  
PEGs are essentially non-irritant to the skin, and they are therefore useful as ointment 
bases. Solid grades are generally employed in topical ointments with the consistency of the 
base being adjust by the addition of liquid grades of PEG.  
Mixtures of PEGs are used also as suppository bases where they have the following 
advantages over fats: the melting point of the suppository can be made higher to withstand 
exposure to warmer climates; release of the drug is not dependent upon melting point; 
physical stability on storage is better; suppositories are readily miscible with rectal fluids. 
Disadvantages are that they are chemically more reactive than fats; the rate of release of 
water-soluble compounds decreases with the increasing molecular weight and the PEGs 
tend to be more irritant to mucous membranes than fat.  
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Aqueous PEGs solutions can be used either as suspending agents or to adjust the viscosity 
and consistency of other suspending vehicles. When they are used with other emulsifier, 
PEGs can act as emulsion stabilizers.  
Liquid PEGs are used as solvents of the contents of  soft gelatine capsules.  
In concentrations up to approximately 30 %v/v PEG 300 and 400 are used as vehicles for 
parenteral dosage form. 
In the solid-dosage formulations, PEGs with high molecular weight can be used to enhance 
the effectiveness of tablet binders and impart plasticity to granules.  
These polymers can also be used to enhance the aqueous solubility or dissolution 
characteristics of poorly soluble compounds by making solid dispersions.  
Another use of PEGs is in the film coating. Solid grades of polymer can be used alone for 
film coating or can be useful as plasticizer in conjunction with film-forming polymer. The 
presence of PEGs in the film coats tends to increase their water permeability. Currently, 
the PEG is the most popular material used to modify the surface of the biodegradable 
nanoparticles in order to reduce their plasma protein absorption and so, to avoid their 
recognition by the reticuloendothelial system (Gref, 2001, Gref et al., 1995). 
PEG with molecular weigh of 6000 and above can be used as lubricants.  
The antibacterial activity of certain antibiotics such as penicillin, and bacitracin, is reduced 
in the PEG bases. Also the preservative efficacy of the parabens may also be impaired due 
to binding with polyethylene glycols.  
Polyethylene glycols are described in many pharmacopeias. Some of them such as the USP, 
have a single monograph describing various different grades; other pharmacopeias have 
individual monographs.  
 
According to the European Pharmacopeia 6.0 the PEG 1500 is defined as “white or almost 
white solid with a waxy or paraffin-like appearance. It is very soluble in water and in 
methylene chloride, freely soluble in alcohol, practically insoluble in fatty oils and in 
mineral oils”.  
The PEG 4000 is defined as “white or almost white solid with a waxy or paraffin-like 
appearance. It is very soluble in water and in methylene chloride, practically insoluble in 
alcohol, and in fatty oils and in mineral oils”. 
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1.6 Diazepam 
 
Diazepam is a long-acting benzodiazepine derivative drug which possesses anxiolytic, 
anticonvulsant, sedative, skeletal muscle relaxant and amnestic properties (Goodman and 
Gilman, 2001). It is commonly used for treating anxiety, insomnia, seizures, alcohol 
withdrawal, and muscle spasms. It may also be used before certain medical procedures 
(such as endoscopy) to reduce tension and anxiety, and in some surgical procedures to 
induce amnesia (Martindale, 2002). 
The mechanism of action of the diazepam is mediated by the enhancement of the activity 
of gamma-aminobutyric acid (GABA), a major inhibitor neurotransmitter in the brain. Two 
subtypes of GABA receptors have been identified: A and B. Benzodiazepines interact with  
GABA receptor (benzodiazepine receptors) that is an integral membrane chloride channel 
(Martindale, 2002).  
Diazepam can be administered orally, intravenously, intramuscularly, or as a suppository.  
When diazepam is administered orally, it is rapidly absorbed from the gastrointestinal tract, 
peak plasma concentrations occurring about 30-90 minutes of oral administration. The 
onset of action is 1-5 minutes for IV administration and 15-30 minutes for IM 
administration. Diazepam is highly lipid-soluble and crosses blood-brain barrier; it acts 
promptly  on the brain, and its initial effects decrease rapidly as it is redistributed into fat 
depots and tissues (Martindale, 2002).  
Diazepam is metabolised via oxidative pathways in the liver by the cytochrome P450 
enzyme system. It has a biphasic half-life of 1-2 and 2-5 days, and has several 
pharmacologically active metabolites including oxazepam, and temazepam. These 
metabolites are conjugated with glucuronide, and are excreted primarily in the urine. 
Diazepam is  98.5% bound to plasma proteins. 
The dosage of diazepam for healthy adults ranges from 2 to 30 mg depending on the 
severity of the indications. For severe anxiety diazepam is given P.O. in doses of 2 mg 
generally three times daily; in case of mild anxiety or insomnia also lower doses are used. 
When given by intravenous injection the dose is usually 100 to 200 µm per kg body-weight.  
The chemical structure and physico-chemical data of the drug are reported in Figure 24. 
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Figure 24. Chemical structure of Diazepam. Systematic (IUPAC) name: 7-chloro-1,3-dihydro-1-methyl-5-
phenyl-2H-1,4-benzodiazepin-2-one 
 
As mentioned before, and also as it can be deduced from the chemical structure, diazepam 
is a hydrophobic molecule and on the Biopharmaceutics Classification System (BCS) it is 
classified as class II: higly permeable, but low soluble drug.  
 
 
 
Chemical structure: C16H13ClN20 
 
Molecular weight: 284.7 g/mol 
 
Physical state: white or almost white 
crystalline powder 
 
Melting point:  131.5 to 134.5 °C 
 
Solubility: slightly soluble in water, 
soluble in alchol, and free soluble in 
chloform
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2. Aim 
 
Aim of this thesis was to set-up a supercritical process, based on the PGSS technique, for 
the production of the microparticulate polymeric drug delivery systems without the use of 
organic solvents. This aim was pursued trough the preliminary study of the phase 
behaviour of the binary systems polymer/CO2, drug/CO2, and the ternary system 
polymer/drug/CO2. 
 
The experimental work was carried out in three steps: 
i) preformulation studies; 
ii) microparticulate drug delivery systems production; 
iii) biopharmaceutical and technological characterization of the obtained microparticles. 
 
Polyethylene glycols and diazepam were selected as model polymer and drug, respectively. 
 
In the first part of the work, the solubility, the swelling, the melting point variation of PEG 
in supercritical CO2, as well as the solubility of SC-CO2 in PEG, the solubility of diazepam 
in PEG in presence of CO2, and the solubility of diazepam in SC-CO2 were measured.  
The knowledge of the PEG/CO2 and PEG/CO2/diazepam phase behaviour allowed to fix 
the operative conditions to set-up the PGSS process. 
Diazepam was chosen as a model drug that can be administered at low dosage to treat 
pathologies such as mild anxiety, panic attack, or insomnia. Diazepam is a higly permeable 
hydrophobic molecule. The high permeability can be exploited for its administration via 
transmucosal or transepitelial route, namely buccal, nasal or pulmonary. However, the low 
solubility negatively influences the absorption rate; for this reason the incorporation of this 
drug into a hydrophilic polymer (such as PEG) potentially would lead to an improved drug 
dissolution rate which would result in a rapid onset of action.   
In the third part of the work, the obtained microparticles were characterized for physico-
chemical properties.  
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3. Materials and Methods 
 
3.1 Materials 
 
PEG 1500 and 4000 with degree of polydispersivity of 1.02 and 1.1 respectively, were 
purchased from A.C.E.F. (Italy); while diazepam was provided by Cambrex (Italy). These 
products  were used as received from the supplier, or after micronization by means of a 
vibration mill. 
CO2 (99.99% pure) was supplied by Sapio (Italy) and used without any further purification. 
Methanol, acetonitrile, cyclohexane, glacial acetic acid HPLC grade (VWR, International 
s.r.l., Italy), distilled water, 1-heptanesulfonic acid sodium salt (Sigma Aldrich, Germany) 
sodium acetate (Merk, Germany) were also used in this study. 
 
3.2 Methods 
 
3.2.1 HPLC assay 
 
PEG 1500 
 
A HPLC (LC-10 ATvp, Shimadzu, Japan) equipped with Refractive Index detector (RID 
10A, Shimadzu, Japan) was used to quantify the PEG 1500. The peak areas were 
integrated using the Cromatoplus software. The analyses were carried out using a size-
exclusion column OHpak, SB-802.5 HQ (Shodex, Japan), and distilled water as mobile 
phase at the flow of 1 mL/min. The injected volume was 100 µL (Rheodyne injector 7725i) 
and the PEG 1500 retention time was 7.6 min. PEG 1500 was quantified by comparing the 
sample signal with that of a standard solution of the polymer.  
 
Diazepam  
 
The HPLC system used to quantify diazepam was composed of a multisolvent delivery 
unit (LC-10 ATvp, Shimadzu, Japan), an autosampler (Waters 2487) and a diode-array 
detector (SPD-10Avp, Shimadsu). The peak areas were integrated using the Cromatoplus 
software. The stationary phase was a Merck octyl derivative silica column (250 × 4.0 mm, 
5-µm particle size) thermostated at 50 °C (CTO-10ASvp, Shimadzu). The mobile phase 
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consisted of 0.5 M sodium acetate tri-hydrate buffer containing 5 mM 1-heptanesulfonic 
acid monohydrate sodium salt and methanol (30:70 v/v), adjusted to pH 6.0 with glacial 
acetic acid. The flow rate was 1 mL/min. Diazepam was monitored at 230 nm. 
 
The HPLC methods used in this work were validated for linearity, accuracy, precision, 
limit of detection and quantification. Furthermore, the number of theoretical plates and 
tailing factor were also calculated. The validations of the analytical procedures were 
carried out according to the guidelines of the international conference of harmonisation, 
ICH Q2 (R1). 
 
Linearity 
 
Linearity shows the method’s ability to obtain results which are proportional to the 
concentration of the analyte within a given range. Linearity is determined by calculating 
the regression line in the plot peaks area obtained by integration vs analyte concentration.  
 
Precision or Relative Standard Deviation (RSD) 
 
ICH defines the precision of an analytical method as “ the degree of agreement among the 
individual test results obtained when the method is applied to multiple sampling of a 
homogeneous sample”. In other words, the precision indicates the reproducibility of the 
analytical method, and it can be determined by using the equation: 
 
100.% ⋅=
mean
dsRSD  [6] 
 
where RSD is the relative standard deviation defined as the percentage ratio between the 
standard deviation (s.d) and the mean value. The USP requires that unless specified by a 
method: 
- if a relative standard deviation of < 2%, is required then five replicate injection should 
be used 
- if a relative standard deviation of > 2%, is required then six replicate injection should 
be used 
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Limit of detection 
 
The limit of detection is the lowest concentration in a sample that can be detected, but not 
necessarily quantitated, under the stated experimental conditions. The limit of detection is 
generally quoted as the concentration yielding a signal-to-noise ratio between 3 or 2.  
 
Limit of quantitation 
 
This is the lowest concentration of analyte in a sample that can be determined with 
acceptable precision and accuracy. It is quoted as the concentration yielding a signal-to-
noise ratio of 10. 
 
Number of theoretical plates (n) 
 
This is a measure of the sharpness of the peaks and therefore the efficiency of the column. 
It can be calculated in various ways, for example the USP, equation 7, uses the peak width 
at the base (Wb) and the BP, equation 8, at half of the height (Wh).  
In Figure 25, the theoretical plate number calculations are reported. 
 
 
Figure 25. Plate number calculation 
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bW
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where Wh is the peak width at ½ peak height, Wb is the peak width at base, and t is the 
retention time. 
In this work, the number of theoretical plates was calculated as described in the USP 30. 
The plates number depends on column length (i.e. the longer the column the larger the 
plate number). Therefore, the column’s efficiency can also be quoted as, the height 
equivalent to one theoretical plate (HETP): 
 
n
LHETP =   [9] 
 
where L is the length of the column. 
 
Tailing factor 
 
The tailing factor is a measure for the symmetry of the peak (Figure 26). 
 
 
 
Figure 26. Tailing factor calculation 
 
The tailing factor is quoted as: 
 
 
f
W
T
2
05.0=   [10] 
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where W0.05 is the width at 5 % of the peak height, and f is the distance between maximum 
and the leading edge of the peak. 
 
3.2.2 Measurement of the density of PEG 1500 and CO2 
 
The density values of the PEG 1500 were calculated at 35 and 55 °C at atmospheric 
pressure. The value at 35 °C was measured by means of a helium pycnometer 
(Multivolume Pycnometer 1305, Micromeritics, USA) as to 1.28 g/mL. PEG 1500 melts at 
ambient pressure between 44 and 48 °C (see DSC), therefore, its density at 55 °C was 
measured by means of calibrated (2 mL) glass pycnometer for liquid; the measured value 
resulted 1.11 g/mL. 
The density values of CO2 at given pressures and temperatures was calculated by means of 
the Refprop software (NIST, MD, USA) (http://www.nist.gov/data/nist23.htm). 
 
3.2.3 High-pressure view cell 
 
A high-pressure view cell (SITEC-Sieber Engineering AG, Zurich, Switzerland) (internal 
volume 74 mL) was used to visualize the behaviour of the PEG 1500 in the presence of 
CO2 at fixed temperature and pressure. The cell is equipped with two sapphire windows 
(diameter 18 mm) facing to each other. The temperature was imposed by a heating jacket 
to within ± 1K (SITEC-Sieber Engineering AG, Zurich, Switzerland) and the pressure by a 
high pressure pump (Teledyne ISCO 260D, Nebraska, USA) with a ± 0.5 % pressure 
gauge monitoring (series D pump controller, Teleodyne ISCO). 
By means of the view cell, the melting point and the swelling of the polymer under SC-
CO2 were measured. 
 
Melting point under SC-CO2 
 
The measurement of the melting points of the PEG 1500 and PEG 4000 under pressure 
was based on a modified capillary method. The polymer (nearly 1 g) was introduced in a 
glass cylinder and placed in the high-pressure view cell. Vacuum was created inside the 
cell (membrane pump KNF, Italy), then, the pressurized CO2 was introduced and heated.  
The melting of the polymer was observed through the sapphire windows and registered 
with a photo camera (Finepix S602 Zoom, Fujifilm).  
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For each analyzes the temperature value was fixed while the pressure increased until the 
polymer melting onset (appearance of the first liquid drop). Each experiment was 
replicated at least twice. 
 
Polymer swelling under SC-CO2 
 
PEG 1500 (1.28 g) was placed in a calibrated glass cylinder (2 mL) and introduced inside 
the high-pressure view cell. After vacuum application, the pressurized CO2 was introduced 
into the cell and heated at the desired temperature. The polymer was kept in contact with 
the CO2 until the attainment of the equilibrium (typically 24 hours). Pictures of the 
polymer containing cylinder were recorded at fixed time until a constant volume was 
reached. 
The obtained images were analyzed by means of Image J software (NIH, Bethesda, USA) 
(http://rsb.info.nih.gov/IJ/) to quantify the polymer volume increase. 
Measurements were carried out at least in triplicate at 35 and 55 °C in the 30-250 bar 
pressure range. 
 
3.2.4 PEG 1500 solubility in SC-CO2 
 
The solubility of PEG 1500 in supercritical CO2 was assayed by means of a laboratory 
scale extractor (Spe-ed SFE, Applied Separation, Allentown, PA, USA) operating under 
dynamic conditions at low CO2 flux (about 4.5 10-3 mol/min) according to the validated 
method described by Stassi et al. (Stassi et al., 2000) and modified by Bettini et al. (Bettini 
et al., 2001) (Figure 27).  
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Figure 27. Schematic representation of the apparatus used for the measurement of PEG 1500 in SC CO2: 1 
CO2 reservoir; 2 chiller; 3 pump; 4 inlet valve; 5 thermostatic chamber; 6 saturation column; 7 outlet valve, 8 
micrometric valve; 9 collecting flask; 10 flow-meter; 11 gas-meter; 12 temperature controller 
 
A stainless steel column with internal volume of 1.2 mL was loaded with 200 mg of 
polymer and placed in a thermostatic chamber at 35 or 55 °C. The CO2 was introduced into 
the column and pressurized to the desired pressure in the 100-400 bar range. The CO2 flow 
rate was tuned by a micrometric valve. 
In a typical isothermal solubility determination, the CO2 flowed through the polymer to 
remove the air, then, the pressure inside the column was raised up to the desired value 
holding the outlet valve closed. After reaching the pressure value, the outlet valve was 
opened and the CO2 passed through the column. The run was stopped when about 0.9 
moles of CO2 had flowed through the column. 
The PEG 1500 dissolved in CO2 was collected in 25 mL distilled water after gas expansion. 
To avoid the risk of missing portion of the solute, at the end of each measurement, the 
micrometrics valve and the connection tubing were repeatedly washed with portion of 
distilled water. The amount of polymer dissolved in CO2 was quantified by HPLC (see 
3.2.1). Each measurement was performed at least in triplicate.  
The average uncertainty for the solubility experiments was calculated from the 
contribution of error for each parameter (e.g. pressure, temperature, etc.) applying the rules 
of the independent variables; the obtained figure resulted above 3.5 %. 
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3.2.5 CO2 solubility in PEG 1500 
 
Solubility measurements of CO2 in PEG 1500 were performed in static conditions at two 
temperatures (35 and 55 °C) and in the 30-250 bar pressure range. The equipment used is 
schematically represented in Figure 28. 
 
 
Figure 28. 1 CO2 reservoir; 2 chiller; 3 pump; 4 inlet valve; 5 thermostatic chamber; 6 needle valve; 7 
saturation cell; 8 needle valve; 9 outlet valve, 10 temperature controller 
  
An accurately weighted amount of PEG 1500 (about 1.5 g) was placed into a stainless steel 
column (internal volume of 9.7 mL) (7) equipped with 2 needle valves (6 and 8). Prior to 
run, the system was weighted (BEL engineering, Monza, Italy, sensitivity, 0.01g), 
introduced in the oven (5) and heated at the desired temperature. Then, the column was 
submitted to vacuum from valve 9 by keeping the valve 6 closed. The valve 6 was opened 
and the CO2 was pumped in with the outlet valve closed to reach the desired pressure 
(Teledyne ISCO 260D, Nebraska, USA).  
After 4 hours system equilibration the valve 6 was closed. Then, the sealed vessel along 
with the two valves was removed and reweighed. 
The weight difference between the PEG 1500 inside the vessel before and after 
equilibration with CO2 gave the amount of CO2 inside the vessel (WCO2c). Part of this last 
was dissolved in the polymer while another amount occupies the empty space in the 
column (Ve).  
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The weight of PEG 1500 loaded in the vessel (WPEG1500), and the true density of the 
polymer (ρPEG 1500) were known, thus it was possible to calculate the space in the column 
that was not occupied by the polymer, namely Ve  by  the equation: 
 
9.7- (WPEG1500 · ρPEG 1500) = Ve  [11] 
 
while the amount of CO2 not dissolved into the polymer (We) was calculated  as: 
 
(Ve – S) ρCO2 = We   [12] 
 
where S is the swelling defined as % of volume variation upon exposure to CO2, and ρCO2 
is the CO2 density at the given pressure and temperature.  
From the difference between the total mass of the CO2 (WCO2c) and We, the amount of CO2 
dissolved in the PEG 1500 was calculated. The solubility of CO2 in the PEG 1500 was 
expressed as weight %. 
The average uncertainty for the solubility experiments was calculated from the error 
contribution for each parameter (e.g. pressure, temperature, etc.) applying the rules of the 
independent variables; the value resulted above 2 %. 
  
3.2.6 ATR-FTIR spectroscopy 
 
For the spectroscopic measurements under pressurized CO2 a heatable Golden GateTM 
(Specac, ltd. UK) support equipped with a specially designed high pressure cell was used 
(Figure 29). 
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Figure 29. Schematic representation of the Golden GateTM support equipped with a specially designed high 
pressure cell 
 
Briefly, the Golden GateTM was used to hold a diamond crystal (ZnSe focusing lenses) 
with an incident angle of 43° (± 1°) and the molten solid polymer specimen in form of film. 
The specimen was positioned on the top of the crystal mounted in the heating plate 
connected with a temperature controller. The temperature imposed by the heating plate was 
to within ± 1K. 
The high pressure unit comprised a cell sealed to the tungsten carbide plate of the Golden 
GateTM and a syringe pump (Teledyne 500D, Isco, USA) imposing the desired pressure, 
that was measured by a pressure transducer (Swagelok, Germany). The accuracy of the 
pressure measurement was ± 0.5%. A Teflon® O-ring positioned between the cell and the 
surface of the tungsten carbide plate ensured a good contact between the cell and the 
surface of the Golden Gate TM avoiding CO2 leaking.  
The ATR-IR spectra were collected by means of Bruker Equinox 55 FT-IR spectrometer 
with a Mercury-Cadmium-Telluride (MTC) detector. The resolution was 2 cm-1, spectra 
were obtained with 16 scans and were recorded in the 3850-590 cm-1 wavenumber range. 
The FTIR images were collected with an IFS 66/S step-scan FTIR spectrometer (Bruker, 
Germany), and a 64 x 64 focal plane array MCT detector. All images were collected with a 
nominal spectral resolution of 4 cm-1. Sixtyfour scans were co-added and averaged giving a 
total acquisition time of ca. 360 s. This macro-ATR imaging approach gives an area image 
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of 1140 x 820 µm2. The rectangular image shape comes from the incident angle of the 
infrared light at the surface of the diamond surface (Chan and Kazarian, 2003). 
 
Measurement of CO2 sorption and PEG 1500 swelling  
 
A small amount of the PEG 1500 (nearly 4 mg) was put onto the crystal surface of the 
Golden GateTM and the temperature was raised up to the melting point. The obtained liquid 
film was slightly pressed against the crystal with a spatula to ensure a uniform surface and 
a good contact between the film and the crystal. Then, the surface of the crystal was cooled 
down to obtain the solid film. 
The high pressure cell was heated at the desired temperature and the spectrum of the 
polymer without CO2 was collected.  
Thereafter, the CO2 was introduced into the cell; then the outlet valve was closed and the 
pressure was raised up to the desired value. The polymer was kept at fixed temperature and 
pressure until the equilibrium was reached (typical time ranging from few minutes up to 
two hours). During this interval spectra were collected at predetermined time: constant 
absorbance of CO2 and PEG bands indicated the attainment of equilibrium. 
The analyses were carried out at 35 and 55 °C in the pressure range 1-200 bar. Spectra of 
pure CO2 in the same conditions were recorded as well. All analyses were performed in 
triplicate and statistical differences were determined by Student’s t-test (two tails, 
unpaired). 
 
Solubility of diazepam in PEG 1500 under SC-CO2 
 
Different polymeric films were prepared to carry out the experiments. 
A mixture of 10 % w/w of diazepam/PEG 1500 was heated up to 55 °C in order to liquefy 
the polymer and stirred until complete diazepam dissolution. Then, after cooling to room 
temperature, a portion of this mixture (nearly 4 mg) was put on the top of the ATR 
diamond. To guarantee an intimate contact between film and the diamond the temperature 
was raised up to 50 °C, and the liquid sample was slightly pressed against the crystal, then 
the surface of the crystal was cooled down. 
A second mixture containing 75 % w/w of diazepam was heated up to 55 °C in order to 
liquefy the polymer and stirred until uniform diazepam dispersion. Then, it was cooled and 
treated as above reported for the mixture containing 10 % w/w of diazepam.  
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To obtain the spectrum of pure drug, a thin powder layer was pressed against the crystal 
using the punch of the golden gate system.  
Both pure materials and the films, prepared as described above, were placed onto the 
diamond surface, and covered with the high-pressure cell. As stated above, the films were 
heated at the desired temperature and the CO2 was introduced into the cell and the pressure 
was raised up to a predefined value. The specimen was kept at the desired temperature and 
pressure until the equilibrium was reached (typical time ranging from few minutes to two 
hours). During this interval spectra were collected at fixed time until constant absorbance 
of the relevant bands which indicated the attainment of equilibrium. The analysis were 
carried out up to 200 bar, at 35 and 55 °C with the ATR-IR (single element) and between 
35 and 95 °C with ATR-IR imaging. 
All experiments were performed in triplicate. 
The quantitative analysis in the FT-IR spectroscopy are usually performed by using the 
Lambert-Beer law, that expresses the relation between the absorbance, A, the concentration, 
c, the beam path length, l, and the absorptivity, ε: 
 
A =εcl  [13] 
 
In the case of diazepam the characteristic C=O (ketone) stretching band (1680 cm-1) can be 
exploited for the drug quantification. However, the molar absorptivity of the diazepam in 
PEG under SC-CO2 is not known. For this reason, diazepam in PEG 1500 was quantified 
by comparing the absorbance of the sample with that of known concentration solutions, 
taking advantage from a previously established linear relationship between absorbance at 
1680 cm-1 and diazepam concentration in PEG (%w/w) (see section 4.5.1).   
 
3.2.7 Solubility of diazepam in SC-CO2 
 
The solubility of diazepam in SC-CO2 at 35 and 55 °C, in the 30-180 bar range was 
measured by Near Infrared (NIR) spectroscopy in transmission. A transmission cell, 
designed for IR spectroscopic studies under pressure, made in stainless steel, sealed with 
two windows in CaF2, with 0.5 cm path length was used. The IR spectra were recorded 
using a Equinox 22 FT-IR spectrometer (Bruker, Germany) with a deuterated triglycine 
sulfate (DTGS) detector. The spectral resolution was 2 cm-1 number of scans, scanning 
range  with an accumulation of 32 scans between 7000 and  950 cm-1. 
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The concentration of diazepam in SC-CO2 was determined from equation 13 using as 
absorbance the height of the peak at 1485 cm-1 (Figure 30). 
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Figure 30. NIR spectra of diazepam in SC-CO2 
 
This last was selected because, contrary to the band at 1680 cm-1, it did not shift or change 
in shape passing from ethanol to CO2 (Figure 31).  
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Figure 31. NIR spectra of  diazepam in SC-CO2 at 35 ° and 175 bar (dashed line) and diazepam in ethanol 
(solid line) 
 
In fact, the molar absorptivity coefficient (ε) of diazepam was measured in ethanol by 
assuming that the perfect overlapping of the spectra in the two solvents (CO2 and ethanol) 
indicates no change in absorptivity (Liu and Parsons, 1969).  
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Linearity between drug concentration in ethanol and absorbance at 1485 cm-1 was verified 
(see section 4.6.1). 
 
3.2.8 Preparation of PEG microparticles loaded with diazepam 
 
A schematic diagram of the PGSS apparatus to prepare the PEG microparticles loaded with 
diazepam is drawn in Figure 32. 
 
                             
Figure 32. 1 CO2 reservoir; 2 chiller; 3 pump; 4 inlet valve; 5 thermostatic chamber; 6 needle valve; 7 
temperature controller; 8 micrometric valve; 9 nozzle; 10 precipitation chamber 
 
The equipment consists in two main units: a thermostatic chamber (5) wrapped with a 
heating jacket (Falc instruments S.r.l., Italy) connected with a temperature controller; and a 
precipitation chamber (10) equipped with a nozzle (0.4 mm diameter).  
An accurately weighted amount (nearly 2 g) of a mixture of PEG and diazepam (drug 
concentration ranging from 9.1 to 15.5% w/w) was placed in the thermostatic chamber. 
Then the CO2 was pumped at the desired pressure.  
Upon interaction with CO2, PEG liquefied allowing the diazepam dissolution into the 
CO2/liquid PEG mixture. After 4 hours equilibration, the solution was expanded through 
the nozzle in a glass precipitation chamber at ambient pressure. This caused a 
supersaturation of the PEG/diazepam system with CO2 and an intense expansion of the gas 
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bubbles which lead to an explosion of the molten material into fine droplets which 
solidified as a consequence of the sudden decrease of temperature and pressure. 
The microparticles were obtained both with PEG 1500 and 4000 at operative conditions 
(75-250 bar and 35 and 55 °C) which were chosen on the basis of the PEG/CO2 and 
PEG/diazepam/CO2 phase equilibria. 
 
3.2.9 Vibration mill 
 
Diazepam, PEG 1500 and 4000 were ground by means of a vibration mill for 10 minutes. 
Diazepam was ground to compare the dissolution behaviour and pulmonary deposition 
with the raw material and the diazepam embedded in the microparticles; while the 
polymers were ground to prepare homogeneous physical mixtures with a particle size 
comparable with those of the microparticles. 
 
3.2.10 Drug content uniformity in the microparticles 
 
In order to evaluate the drug content uniformity of the obtained microparticles. Three 
samples randomly taken for each batch were analyzed upon dissolving 30 mg of 
microparticles in a 50 mL of acetonitrile/water mixture (60:40 v/v). The obtained solution 
was analyzed by HPLC (see section 3.2.1). 
 
3.2.11 Powder x-ray diffraction (PXRD) 
 
The X-ray powder diffraction is a technique using the electromagnetic radiation of 
wavelength about 1 Å (10-10 m) on powder for structural characterization of the materials.  
X-rays are generated within a sealed tube that is under vacuum. A current is applied that 
heats a filament within the tube; this creates the electron emission. The high voltage of the 
current applied within the tube accelerates the electrons which then hit a target (generally 
Cu). When these electrons hit the targets the X-rays are produced. X-rays are collimated 
and directed onto the flat specimen, and then diffracted at angles that satisfy the following 
condition of Bragg’s equation 14. 
 
θλ sin2dn =   [14] 
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where n is the diffraction order, d is the lattice interplanar spacing of crystal (specimen), θ 
is the X-ray incident angle (Bragg angle) and λ is the wavelength characteristic of the X -
rays (due to the X -ray tube). 
The powder diffraction data are usually presented as a diffractogram in which the 
diffracted intensity I is shown as function of the scattering angle 2θ. 
X-ray diffraction patterns on powder, reported in this work, were recovered on a Rigaku 
MiniFlex diffractometer (Japan) using CuKα radiation 30 kV, 15mA at a scanning speed of 
0.5 °/min with a scanning range (2θ) from 2° to 35°. 
PXRD measurements were carried out to characterize the raw material, to determine the 
polymorphic purity, and to measure the crystallinity of the diazepam contained in the 
micropaticles.  
The crystallinity was quantified by comparing the intensity of the peak characteristic of 
diazepam in the microparticles with that of a PEG/diazepam mixture of known 
concentration. The peak at 2θ=9.5 was exploited for the drug quantification because it 
showed a detectable intensity at did not overlap with the peaks of PEG (Figure 33). 
 
 
 
 
Figure 33. X-ray diffraction patterns on powder of diazepam (green line), PEG (red line) and a 
diazepam/PEG mixture (blue line) (panel a). Panel b is a zoom of the ringed zone in the panel a 
a
b
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The analyses were carried upon establishing linear relationship between the intensity of the 
peak at 9.5 2θ and diazepam concentration in PEG (% w/w).  
PEG/diazepam mixture of known concentrations were obtained by simple, gentle mixing 
of the products (both diazepam and PEG 4000) micronized with a vibration mill. The 
micronization of the products was carried out to obtain the materials with same size to 
achieve an even distribution of components and to avoid preferential orientation of 
particles crystals. Noteworthy, it was tested that the micronization of both diazepam and 
PEG did not change PXRD patterns. 
 
3.2.12 Differential scanning calorimetry (DSC) 
 
DSC is a thermoanalytical technique which measures the amount of energy (heat) absorbed 
or released by a sample when is heated, cooled, or held at constant temperature.  
In a typical experiment both the sample and reference are positioned inside a single furnace 
and subjected at the same temperature program. The DSC detects the difference in the 
amount of heat flow between the sample and the reference, due to exothermic or 
endothermic processes that can occur to the sample during the temperature scanning.    
Typical applications include determination of melting point temperature, heat of melting, 
glass transition temperature, crystallization studies, and identification of phase 
transformations. 
The DSC used in this work to characterize the raw materials was a Mettler Toledo DSC 
821e (Mettler Toledo, USA). Scans of PEG 1500 and 4000 were carried out under a flux of 
dry nitrogen (100 mL min-1) with a temperature program from 20 to 80°C, from 80 to 20 
°C and again 20 to 80 °C, at 10 K min-1. Diazepam was scanned from 25 to 150 °C, at 10 
K min-1. 
Calibration of temperature and enthalpy values was performed with Indium. 
 
3.2.13 Scanning electron microscopy (SEM) 
 
The morphological analyses of the raw materials and particles were carried out by means 
of a scanning electron microscopy (Jeol 6400, Jeol, Japan). Samples were coated with 
graphite (0.001 µm thickness) by evaporation under vacuum, and they were analyzed at a 
distance of 18-21 mm using a tension of 15 KV. 
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3.2.14 Laser diffraction particle size analysis 
 
The laser diffraction particle size analysis is a technique useful to characterize particles 
with a dimension ranging from 0.05 to 3500 µm. In this technique a representative cloud or 
‘ensemble’ of particles passes through a broadened beam of laser light which is scattered 
from the particle with an angle which is inversely proportional to the dimension of particle 
itself.   
The particle size distribution obtained with this technique is expressed as the volume-
equivalent diameter which is defined as the diameter of a sphere having the same volume 
as the particle. 
The samples were analyzed by suspending the dry microparticles in a Span 85/cycloexane 
solution (0.1 % p/v) saturated with diazepam. The suspension was sonicated for 10 minutes 
before analysis. Measurements were repeated 5 times for each sample and three samples 
were measured per batch using a randomised sampling procedure. 
The analyses were carried out with 100 mm lens corresponding to a dimensional range of 
0.2-180 µm. The results are expressed in terms of dv 0.1, 0.5 and 0.9 which represent the 
diameters at 10, 50 and 90 % cumulative volumes, respectively. 
 
3.2.15 Aerodynamic assessment using Andersen Cascade Impactor (ACI) 
 
The pulmonary deposition of the raw diazepam and the microparticles obtained by PGSS 
was analyzed by means of an Andersen Cascade Impactor (ACI) (Copley Scientific, UK) 
by using Turbospin® as aerosolisation device, following the procedure described in the 
USP 30.  
 
Turbospin® 
 
The dry powder inhaler device (DPI) used in this work to study the pulmonary deposition 
was Turbospin (PH&T, Milan, Italy). This is a medium resistance DPI, with a resistance of 
0.09 cm (H2O1/2) L min−1 (Meakin et al., 1996), that works at 60 L/min. 
In Figure 34, a picture of the device with all its components is reported.  
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                                                     a          b          c           d 
Figure 34. Picture of Turbospin with its components: a cap, b capsule with drug, c mouthpiece, d body device 
The size #2 capsule, containing the powder to be aerosilized, is positioned inside the body 
of the device in the capsule chamber, and closed with the mouthpiece. After the piercing of 
the capsule with a needle contained in the body device, the powder is delivered through 
vacuum induced by the patient’s inspiration. The Turbospin utilizes shear during rattling of 
the capsule, generated by the airflow through vents along the side of the capsule chamber, 
and jetting of the airstream at the restriction in the mouthpiece to deagglomerate and 
disperse the powder (Meakin et al., 1996). 
Size 2 Hydroxypropyl Methylcellulose capsules were purchased from Qualicaps Europe 
S.A. (Spain) for use with the Turbospin® device. The capsules were loaded with 10±1 mg 
of microparticles. 
 
Andersen Cascade Impactor  
 
ACI allowed to know a detailed aerodynamic size distribution (eight different stage) which 
corresponds to the stage of the vivo deposition (Figure 35). 
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Figure 35. Aerodynamic size distribution of the ACI stages and corresponding areas of the vivo deposition 
 
ACI consists of 8 aluminium stages and a final filter. The stages were clamped together 
and sealed with O-rings. The aerosolization device was connected to the stages by means 
of a right-angle bend metal induction port. A suitable mouthpiece adapter was used to 
provide an air-tight seal between the inhaler and the introduction port.  
The analyses were performed at a flow rate of 60 L/min (Q) which produced a pressure 
drop across the inhaler of 4.0 KPa (TPK 2000, Copley Scientific, UK). Since ACI is 
calibrated at 28.3 (± 5%) L/min of air, while the aerosolization device requires an air flow 
of 60 L/min, to work properly, the equation 15 was applied to determine the cutoff 
diameter of each individual stages of the impactor at 60 L/min: 
 
2
1
,50,50 ⎟⎠
⎞⎜⎝
⎛⋅= QQnDD QnQ   [15] 
 
where D50,Qn is the cutoff diameter of each stage at the flow rate, Q, employed in the test, 
and the subscript, n, refers to the nominal  values determined when Qn equals 28.3 L/min. 
The test flow duration, T, was calculated by using the equation: 
 
T =240/Q   [16] 
 
and it resulted to be 4 seconds. This time was calculated in order that a volume of 4.0 litres 
of air ± 5 % is withdrawn from the inhaler during the withdrawal of the test dose.  
The collection plates of ACI were coated with a solution of span 85 in cycloexane (1 % p/v) 
to avoid the rebounding of the solid particles inside the instrument.  
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Each batch was analyzed in triplicate.  
Each analysis was carried out by acting the device 10 times through the ACI to obtain a 
HPLC-detectable amount of drug. Then the impactor was dismantled and each stage was 
separately washed with a mixture of acetonitrile: water 60:40 v/v. The obtained solutions 
were filtered (PTFE 0.45 µm, Sartorious, Italy) and analyzed by HPLC with a method 
described previously for diazepam quantification. 
 
The following parameters were calculated according to the USP: 
 
Recovery. It is defined as the percent of the ratio between the mass of the drug deposited 
on each stage, induction port, mouthpiece and adapter, and the mass of the drug emitted 
from the Turbospin®. The recovery value must to be in the 75-125 % range, if the value is 
outside this range the test must be repeated.  
Fine Particle Dose (FPD). It is defined as the mass (mg) of the drug with a particle size 
less then 5 µm. It is calculated as: 
 
⎟⎠
⎞⎜⎝
⎛=
N
RFPD    [17] 
where R is the total mass of the drug less the 5 µm an N is the number of dose discharged 
during the experiments. 
R was determined by interpolation from a plot which reports the cumulative percentage of 
drug mass below than stated aerodynamic diameter in probability scale, versus the cutoff 
diameter in logarithmic scale.  
Fine Particle Fraction. It is defined as the % of the mass of the drug less the 5 µm. It was 
calculated by using the equation: 
 
100⋅⎟⎠
⎞⎜⎝
⎛
Σ= A
RFPF    [18] 
 
where R is the total mass of the drug less the 5 µm an ΣA represents the total mass of the 
drug recovered from the impactor.  
MMAD (Mass Median Aerodynamic Diameter). It is defined as the median particle 
diameter of the formulation depositing within the ACI. A diagram which reports the 
cumulative percentage of drug mass less than stated aerodynamic diameter versus the 
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cutoff diameter was drawn. The MMAD was determined as the diameter which 
corresponds to 50 % of the cumulative fraction (Figure 36). 
 
 
 
Figure 36. Plot of cumulative percentage of drug mass less than stated aerodynamic diameter versus the 
cutoff diameter  
   
Delivered Dose. It represents the dose delivered from the Turbospin®, and it is calculated 
as the weight difference of the device before and after the dose discharging. 
 
3.2.16 Nasal deposition 
 
The microparticles nasal deposition of the microparticles was studied with a silicon cast of 
the human nasal cavity, using MIAT® as insufflator device . 
 
MIAT® 
 
MIAT® ( MIAT S.p.A., Italy) includes a smooth plastic bottle (blue part) with a simple jet 
outlet (Figure 37).  
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Figure 37. MIAT® insufflator device 
 
A size #2 gelatine capsule was filled with an exactly weighted amount of microparticles 
which corresponded to a diazepam dose of 1 mg.  
The capsule was positioned inside the jet outlet and pierced with a needle. Then, by 
pushing the plastic bottle the air inside the container was pressed out of the small nozzle, 
thereby nebulizing the powder contained in the capsule.  
By releasing the pressure again air was drawn inside the bottle.  
 
Silicon cast 
 
The powder contained in a capsule was sprayed in the silicon cast (Figure38).  
 
 
 
Figure 38. Silicon cast of the human nasal cavity  
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The deposited powder was repeatedly washed with a mixture of acetonitrile: water 60:40. 
The drug amount in the obtained solution (corresponded to the deposited drug) was 
measured by HPLC with a method described previously.  
For each batch, three samples were randomly taken and sprayed inside the cast to analyze 
the nasal deposition. 
The nasal deposition was calculated as the percent of the ratio between the mass of the 
drug deposited on the cast (analyzed by HPLC) and that emitted from the MIAT®. The 
dose delivered from the MIAT® was calculated as the weight difference of the device 
before and after the discharging during the experiment.   
 
3.2.17 Dissolution studies 
 
The rate of drug dissolution from the microparicles was studied by using a flow-through 
apparatus described in the USP 30.  
The apparatus consists in three parts: a reservoir for the dissolution medium, a pump that 
forces the dissolution medium upwards through the flow-through cell, and the flow-
through cell. The dissolution medium was purified water at ambient temperature.  
In a typical experiment, by using the pump, water was introduced through the bottom of 
the cell to obtain a suitable continuous flow through an open circuit at a flow rate of 5 
mL/min. After few minutes of equilibration, air starts to escape through the capillary tube 
and the chamber, and an exactly weighted amount of each samples (corresponding on the 
basis of the drug content at 10 mg of diazepam) were placed in the flow-through cell. 
The microparticles spread through the dissolution medium according to its physico-
chemical properties. Samples, at fixed time, were collected at the outlet of the cell and 
analyzed by HPLC.  
The dissolution behavior of pure diazepam, micronized diazepam, and of diazepam from 
physical mixture and from microparticles prepared by PGSS were analyzed.  
The diazepam was micronized by means of a vibration mill for 10 minutes obtaining the 
microparticles characterized in the section 4.3.  
The physical mixture of micronized diazepam and micronized PEG 4000 was obtained by 
simple gentle mixing. For the binary mixture PEG 4000 micronized was used with a 
vibration mill until its particles size was close to that of diazepam. The reasons were to 
achieve a randomly even distribution of components and do not influence the dissolution 
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behavior. The concentration of the physical mixture investigated was chosen (10 % w/w) 
to be comparable to that of the microparticles obtained by PGSS.  
All the analyses were made in triplicate. 
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4. Results and Discussion 
 
4.1 HPLC method validation 
 
4.1.1 PEG 1500 
 
The PEG 1500 was quantified by using HPLC according the method described in the 
section 3.2.1. A calibration curve was drawn using eight PEG 1500 solution in water 
having different concentrations (Figure 39). 
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Figure 39. Area of the peaks vs diazepam solution concentrations 
 
Each solutions was injected five times and the linearity, precision (expressed as relative 
standard deviation, RSD %), limit of detection, limit of quantitation, number of theoretical 
plates and tailing factor of the assay were calculated. 
The correlation coefficient (R2) for the calibration curve was 1 within a range of 0.0127-
0.7718 mg/mL which indicates a good linearity.  
The reproducibility of the method was considered acceptable as the RSD% values obtained 
for each standard was < 2%, limit defined by the guidelines ICH Q2 (R1) (Table 5). 
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Table 5. Standard deviation (n=5) and RSD% values of sample solutions of different concentration samples 
 
          Concentration (mg/mL)           mean AUC       standard deviation              RSD % 
                0.0127                                      10412                      99                         0.95 
                0.0213                                      18190                    285                         1.50 
                0.1029                                      81367                    542                         0.67 
                0.2058                                    164343                  1308                         0.80 
                0.3293                                    263142                  3200                         1.22 
                0.4116                                    330956                  2787                         0.84 
                0.6174                                    499073                  4313                         0.86 
                0.7718                                    620694                  6473                         1.04 
 
 
The limit of detection was 0.0038 mg/mL; the limit of quantitation was 0.0127 mg/mL; the 
number of theoretical plates was 2038; and the tailoring factor was 1.05.   
 
4.1.2 Diazepam 
 
Diazepam was quantified by using HPLC accordingly with the method described in the 
section 3.2.1. A calibration curve was drawn using six diazepam solutions at different 
concentrations dissolved in acetonitrile:water, (60:40) (Figure 40). 
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Figure 40. Area of the peaks vs diazepam solution concentrations 
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Each solutions was injected five times and the linearity, precision, limit of detection, limit 
of quantitation, number of theoretical plates and tailing factor of the assay were calculated. 
The correlation coefficient (R2) for the calibration curve was 0.9996 within a range of 
0.0103-0.0860 mg/mL which indicates a good linearity also in this case. The 
reproducibility of the method was considered acceptable (RSD < 2%) (Table 6). 
 
Table 6. Standard deviation (n=5) and RSD% values of different concentration samples 
 
          Concentration (mg/mL)           mean AUC       standard deviation            RSD % 
                0.0103                                   573224                   10466                         1.83 
                0.0275                                1723207                     7421                         0.43 
                0.0344                                 2104464                   25914                         1.23 
                0.0602                                 3627897                   34841                         0.96 
                0.0688                                 4121260                   68677                         1.67 
                0.0860                                 5215457                   78409                         1.50 
 
The limit of detection was 0.75 µg/mL; the limit of quantitation was 2.87 µg/mL; the 
number of theoretical plates was 12247; and the tailoring factor was 0.94.   
 
4.2 PEG 1500 and 4000 characterization 
 
PEG 1500 and 4000 particles appear like waxy flakes of big dimension (Figure 41). 
 
Figure 41. Scanning electron microscopy image of PEG 1500 (20X) 
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PEG 1500 and 4000 are solid, semicrystalline polymers with a melting point, measured by 
DSC, of 50.1 and 58.5 °C, respectively. In Figures 42 and 43 the DSC of the PEG 1500 
and 4000 are reported. 
 
                 
 
Figure 42. DSC trace of the PEG 1500 
 
The DSC trace of PEG1500 shows an endothermic peak at 50.1 °C indicatives of melting. 
By temperature decreasing the liquid PEG 1500 recrystallized, and the melting point after 
recrystallization, was at 48.6 °C. 
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Figure 43. DSC of the PEG 4000 
 
The DSC trace of the PEG 4000 shows a similar trend (Figure 43). The melting point was 
at 58.5 °C, and the fusion after recrystallization was at 54.6 °C. The melting curve of the 
PEG 4000 shows a double peak probably due to the polidispersivity of the polymer.   
PEG 1500 and 4000 micronized powders were analyzed as well.  
In Figure 44 and 45 the DSC of the two micronized polymers were reported.  
 
               
 
Figure 44. DSC of the micronized PEG 1500 
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Figure 45. DSC of the micronized PEG 4000 
 
In the case of the micronized polymer the melting points were 49.3 °C for the PEG 1500 
and 55.3 °C for PEG 4000. In summary, the recrystallization as well as the milling induce 
a small reduction of both PEG melting points. 
PEG 1500 and 4000 were also characterized by X-ray diffraction. In Figure 46 and 47 the 
powder X-ray powder diffraction pattern of the PEG 1500 and 4000 as raw, micronized 
and recrystallized after fusion  material are reported. 
 
 
 
Figure 46. X-ray powder diffraction of PEG 1500 raw material, micronized powder and recrystallized after 
fusion 
 
Integral -1665,69 mJ
  normalized -182,34 Jg^-1
Onset 51,48 °C
Peak 55,39 °C
Endset 60,03 °C
Left Limit 41,49 °C
Right Limit 64,45 °C
Heating Rate 10,00 °Cmin^-1
Left Area 58,33 %
Right Area 41,67 %
mW
20
min
°C20,0 25,0 30,0 35,0 40,0 45,0 50,0 55,0 60,0 65,0 70,0 75,0
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5 5,0 5,5
^exo
 SW 8.10eRTASLab: METTLER
flakes 
micronized 
recrystallized after fusion 
 
Results and Discussion  
 75
The peaks of the micronized and recrystallized PEG 1500 were shifted with respect to that 
of the raw material. This can be ascribed to the different particle size. The raw material is 
like flakes of 3 mm in diameter, the micronized polymer are microparticles of 40 µm, and 
the product recrystallized after fusion is a thin film. Particles with different size and shape 
may diffract the beam with different orientation eventually leading to a shift of the peaks 
position. 
It is possible to note also that the micronized and recrystallized products are less crystalline 
(lower peaks intensity) with respect to the raw material. This confirms the observation 
already made for DSC data. 
In Figure 47, the PEG 4000 raw material, micronized powder and recrystallized after 
fusion are reported. 
 
 
 
Figure 47. X-ray powder diffraction of PEG 4000 raw material, micronized powder and recrystallized after 
fusion 
 
In the case of the PEG 4000 it is possible to make the same considerations. The peaks of 
the micronized and recrystallized PEG 4000 were shifted respect to that of the raw material, 
although the phenomenon is less evident than in the case of PEG 1500. Furthermore, also 
in the case of the PEG 4000, the micronized and recrystallized products were less 
crystalline respect to the raw material. 
 
4.3 Diazepam characterization 
 
Diazepam is a white crystalline powder, as demonstrated by the X-ray difractogram 
reported in Figure 48, with a melting point of 132.5 °C (Figure 49). 
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Figure 48. X-ray powder diffraction of  diazepam 
 
 
 
 
Figure 49. DSC trace of diazepam 
 
The particle size distribution of the diazepam was measured by laser light scattering. In 
Table 7, the results, expressed as volume diameter are reported. 
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Table 7. Particle size distribution of diazepam with the standard deviation (n=3) 
 
 
Material                       dv 0.1 (μm)                   dv 0.5 (μm)                    dv 0.9 (μm) 
 
Diazepam                        14.5 (0.29)                    42.1 (1.9)                         98.0 (9.6) 
 
Furthermore, the morphology of the diazepam particles was analyzed by using SEM 
(Figure 50).   
 
Figure 50. Scanning electron microscope images of diazepam raw material 
 
The SEM images show that the crystals of the raw material were irregular with a 
dimension varying between 10-40 µm in agreement with the results obtained by the laser 
diffractometry (Table 7).   
It was also produced a batch of diazepam particles micronized by means of a vibration mill 
in order to obtain particles dimension comparable with that of the microparticles obtained 
by PGSS (see beyond). The data of the particle size distribution are reported in Table 8. 
 
 
 
 
 
 
 
 
           
100 µm, 130X                                              30µm, 150X 
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Table 8. Particle size distribution of diazepam obtained by vibration mill with the standard deviation (n=3) 
 
 
       Material                                 dv 0.1 (μm)                   dv 0.5 (μm)               dv 0.9 (μm)       
 
    Vibration mill diazepam              2.1 (0.6)                         15.1(1.4)                  40.8 (7.8) 
                   
 
It has to be underlined that the dimensional distributional curve obtained with laser 
diffraction was bimodal, showing the presence of a population of particles with a smaller 
diameter (Figure 51). 
The micronization with the vibration mill led to a poor control of the particle size 
distribution (demonstrated by the bimodal curve) and to an increase of surface energy with 
increased tendency to adhesion and agglomeration. Furthermore, the micronized particles 
showed a high electrostatic charge. 
 
 
 
Figure 51. Dimensional distribution curve of diazepam micronized by a vibration mill 
 
The pulmonary deposition of pure and micronized diazepam were carried out by means of 
ACI and using Turbospin® as device. 
Data of the pulmonary deposition with the calculated parameters according to the USP are 
reported in Figure 52 and 53. 
 
Particle Diameter (µm.)
%
0 
10 
20 
 0
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
   0.1    1.0   10.0  100.0
Results and Discussion  
 79
 
Diazepam raw material 
 
Drug emitted for shot (mg)              8.8 ± 0.41 
Recovery (%)                                    112 ± 12  
MMAD (µm)                                     14.4 ± 2.5 
Fine particle fraction (%)                9.7 ± 1.81 
Fine particle dose (mg)                     0.76 ± 0.08         
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Figure 52. Aerodynamic parameters (Table), and drug distribution % in the ACI  
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Diazepam obtained with a vibration mill 
 
Drug emitted for shot (mg)              9.9 ± 0.09 
Recovery (%)                                    98.2 ± 11.7  
MMAD (µm)                                     6.7 ± 0.77 
Fine particle fraction (%)                25.3 ± 2.9 
Fine particle dose (mg)                     2.65 ± 0.37    
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Figure 53. Aerodynamic parameters (Table), and drug distribution % in the ACI   
 
4.4 PEG/CO2 binary system 
 
To find the most appropriate operative conditions to prepare microparticulate drug delivery 
systems by PGSS technique, the binary system PEG 1500/CO2 was studied. 
In particular, the PEG 1500 and 4000 melting point variation, and the PEG 1500 swelling 
under SC-CO2 were measured. Furthermore, the PEG 1500/CO2 mutual solubility was 
performed. The solubility of CO2 in PEG 1500 was carried out by means of two different 
techniques: gravimetric, and spectroscopic (ATR-FTIR). 
 
4.4.1 Melting point under Supercritical CO2 
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The measurements of the melting points of the PEG 1500 and 4000 under pressure were 
carried out by means of a high pressure view cell by a method that is a modified capillary 
method. The obtained data are shown in Figure 54, where the PEG 1500 and PEG 4000 
melting points are reported as a function of the CO2 applied pressure. 
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Figure 54. Melting temperature of the PEG 1500 (solid circle) and PEG 4000 (empty circle) in the presence 
of CO2 at different pressures, along with the equations of the linear regressions of the experimental data in 
the 1-80 and 1-65 bar range for PEG 1500 and PEG 4000, respectively 
 
In the 1-2 bar pressure range, the melting point (Tm) of PEG 1500 slightly increased (1 °C), 
while from 2 to 87 bar a decrease was observed. Then, no further change was observed up 
to 150 bar. 
As already stated by Shieh and Yang (Shieh and Yang, 2005), the first observed 
phenomenon was probably due to the crystallinity of the polymer, and it might be 
attributed to an increase in the crystal thickness during CO2 exposure (Lian et al., 2006). 
After 2 bar, the PEG 1500 melting point decreased, and the extent of the melting point 
depression was directly related to the amount of absorbed CO2, which, in turn, depended 
on the applied pressure. 
The melting point depression as a function of pressure was determined for PEG 4000 as 
well. The behaviour of the higher molecular mass polymer paralleled that of PEG 1500: 
after a slight Tm initial increase, a linear decrease of the melting point was observed up to 
65 bar, than Tm levelled off. This indicates that the capability of the CO2 to reduce the 
polymer melting point, and therefore to act as a plasticizer, is independent of the polymer 
molar mass. The shift between the two curves presented in Figure 54 depends, only on the 
different initial Tm value. 
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The reported data are in good agreement with those from the literature (Weidner et al., 
1997), and are accordingly interpreted in terms of solubility effect, namely as melting point 
depression of a pure component due to the incorporation of a diluent in a melt (Lian et al., 
2006). These authors found that many polymers exhibit, at low pressure, CO2-induced 
melting point decrease linearly dependent on pressure, followed by an approximately 
constant region at higher pressure. By using numerous experimental data (also from 
literature) they developed a method using the Clapeyron equation for two components, 
three-phase equilibrium, for predicting the lowest melting temperature for crystalline 
polymer in the presence of CO2. These authors, demonstrated that, at low pressure, the 
simplified form of Clapeyron equation indicates that the melting temperature decreases 
linearly with pressure. Linear regression was applied to experimental data at low pressure 
(linear region) in order to determine the slope, dTm/dP. The melting point variations 
between the experimental and theoretic data were compared. The obtained melting point 
variation of PEG 1500, dTm/dP, was 2.62 and 2.41 for the experimental (Weidner et al., 
1997) and the theoretical data, respectively, quite in agreement with the dTm/dP = 2.48 
found in the present work. As far as the PEG 4000 is concerned the theoretical, literature 
(Weidner et al., 1997) and this work figures for dTm/dP were 2.1, 2.03 and 2.22 
respectively. 
 
4.4.2 Polymer swelling under Supercritical CO2 by using the high-pressure view cell 
 
The absorption of the dense gas into the polymer was also associated to the swelling, in 
fact the CO2 solubilizes into the PEG 1500 increasing its volume. 
In the Figure 55 the volume equilibrium degree of swelling % reported as function of CO2 
pressure at 35 and 55 °C can be observed.  
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Figure 55. Percentage of swelling (v/v) of the PEG 1500 as function of CO2 pressure at 35 and 55 °C in the 
30-250 bar pressure range. The bars represent the standard deviation (n=3) 
 
At fixed pressure the volume equilibrium degree of swelling, Q, was calculated as:  
Q = 100⋅−
i
if
V
VV
  [19] 
Where, Vf and Vi are the polymer volume after and before exposure to CO2 respectively. 
PEG 1500 swelled with pressure up to 100 bar, thereafter the polymer volume remained 
practically constant. The maximum Q value was 34.6 and 33.2 % v/v at 35 and 55 °C, 
respectively. The temperature did not have a significant effect: the two swelling curves 
were practically superimposed. 
 
4.4.3 Solubility of PEG 1500 in Supercritical CO2  
 
In Figure 56 the solubility of PEG 1500 in CO2 at 35 and 55 °C and in the 100-400 bar 
pressure range are reported as mole fraction vs pressure. 
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Figure 56. Mole fraction of PEG 1500 dissolved in SC-CO2 versus pressure at two different temperatures. 
The bars represent the standard deviation (n = 5) 
 
The PEG 1500 shows a low solubility in SC-CO2. The solubility increased with the 
pressure, while it decreased with temperature likely due to the CO2 density change. It can 
be observed that the measured solubility values are rather low, although not negligible, due 
to the fact that the CO2 is a small molecule with a weak dipolar moment, thus, it cannot 
easily dissolve large hydrophilic molecule such as PEG 1500. The obtained figures were in 
the order of 10-6 mole fraction, namely one order of magnitude lower than those reported 
by Dasneshvar et al. (Daneshvar et al., 1990, Duarte, 2006) for PEG 1000 at 50 °C. 
Experimental data were correlated with the heuristic model proposed by Giddings and co-
workers (Giddings et al., 1968). These authors demonstrated that the solubility of stearic 
acid, PEG 1000, and PEG 4000 in a very high pressure range (27-190 MPa) can be 
expressed as a function of the CO2 solubility parameter and fitted by means of a second 
degree equation: 
log X = aδ 2  + bδ + C [20] 
where X is the solute mole fraction, a and b are coefficients, C is a constant and δ is the 
solubility parameter of the CO2 at a given pressure and temperature.  
The solubility parameter, δ, of a given compound can be calculated according to 
Hildebrand and Scott (Hildebrand and Scott, 1950) from the square root of the cohesive 
energy, Ecoh, divided by the molar volume, V: 
 
Results and Discussion  
 85
δ = 
V
Ecoh   [21] 
 
Giddings an collaborators (Giddings et al., 1968) stated that the solvent power of a gas 
depends in part on its state relative to its critical condition. The influence of the state, 
which depends on pressure and temperature was defined as state effect. Besides a chemical 
effect, unique to each chemical species depending on its polarity, acid-base properties, and 
hydrogen bonding tendency have to be considered. Solvent power differences among 
liquids depend only on the chemical effect, which is expressed by equation 21. Once a 
dense gas is employed as a solvent reduced density is the principal variable of the state 
effect, which reflects average distances and interactions between molecules. 
Thus, the solubility parameter of a compressed gas can be calculated by the equation 
(Giddings et al., 1968): 
δ = 1.25 Pc 21  [ ρr / ρr (liq) [22] 
where Pc is the critical pressure in atmospheres and the ρr is the reduced density expressed 
as: 
ρr = 
c
a
ρ
ρ    [23] 
here, ρa is the CO2 density at the  given pressure and temperature and ρc is the critical 
density (for CO2 = 0.458 g/mL). The parameter ρr (liq) is the reduced density of the liquid 
that, for CO2 is 2,66 g/mL. Here the state effect can be identified with the second term of 
the right end side of equation 22, [ρr / ρr (liq)], while the first term, 1.25 Pc 21 , is 
associated with the chemical effect. 
The density values at given pressures and temperatures, calculated using the Refprop 
software are reported in Table 9 along with the relevant solubility parameter calculated 
with equation 22.  
The PEG 1500 solubility parameter was calculated with the method of group contributions 
according to Hildebrand and Scott (Hildebrand and Scott, 1950) as 11.07 √cal/cm3. The 
difference between the solubility parameters of SC-CO2 and the polymer justifies the 
observed low solubility of PEG 1500 at the studied temperatures and pressures. In fact, the 
solubilization of a solute in a solvent is favoured when the solubility parameters of both 
solvent and polymer are equal (Hildebrand and Scott, 1950). 
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Table 9. Density values and solubility parameters of CO2 at different temperatures and pressures. 
 
Temperature 
(°C) 
Pressure 
(bar) 
Density 
(g/cm3) 
δ 
√(cal/cm3) 
35 75 0.27 2.38 
35 85 0.61 5.38 
35 100 0.71 6.21 
35 150 0.81 7.10 
35 200 0.86 7.54 
35 250 0.90 7.84 
35 300 0.93 8.12 
55 75 0.18 1.59 
55 85 0.23 1.98 
55 100 0.32 2.83 
55 150 0.65 5.69 
55 200 0.75 6.57 
55 250 0.81 7.06 
55 300 0.85 7.45 
55 400 0.91 7.89 
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Figure 57. Logarithm of PEG 1500 mole fraction in SC-CO2 versus the solubility parameter of the solvent 
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The values of the logarithm of the dissolved polymer mole fraction were plotted versus the 
relevant δ values (see Table 9) for the two studied isotherms (Figure 57).  
The obtained data were fitted to a second degree polynomial equation in order to obtain the 
a and b coefficients and the constant C of equation 20 (R2 = 0.993 and 0.999 at 55 and 35 
°C respectively). From the data reported in Figure 57 it can be noticed that at lower δ 
values, namely at lower density, for the same solubility parameter (corresponding the same 
density) the solubility of PEG 1500 at 55 °C is higher than at 35 °C. This difference 
decreases with δ increase since, not surprisingly, the two curves tend to a common 
maximum value that was calculated as –b/2a. At these points the solubility parameter were 
δ 11.66 √cal/cm3 at 55 °C and δ 11.29 √cal/cm3 at 35 °C. Indeed these figures are very 
close to that of δ calculated for PEG 1500 (11.07 √cal/cm3). 
In agreement with the Hildebrand and Scott theory (Hildebrand and Scott, 1950) as well as 
with the model proposed by Giddings and co-workers (Czubryt et al., 1970) the maximum 
of the curves in Figure 57 represents the highest concentration that can be achieved by 
PEG 1500 in the dense gas. The solubility of the polymer at this point was calculated from 
equation 20 and resulted 3.23·10-4 and 3.39·10-4 mole fraction at 35 and 55 °C, 
respectively. 
On the other hand, equation 20 can be used also for predicting the solubility of the PEG 
1500 in dense CO2 at those densities (namely temperatures and pressures) at which the 
solubility is too low to be determined experimentally. In Table 10, the solubility data 
calculated at 7.5 and 8.5 MPa for the two studied temperatures are reported. 
 
Table 10. Mole fraction of PEG 1500 in carbon dioxide, XG, and solubility parameter at 35 and 55 °C and 7.5 
and 8.5 MPa 
 
T ( °C) P (bar) δ XG 
35 75 2.38 2.85·10-13 
35 85 5.33 2.04·10-8 
55 75 1.59 3.48·10-19 
55 85 1.98 5.27·10-18 
 
It can be noticed that the solubility of PEG 1500 at 55 °C at both pressures is practically 
negligible, while at 35 °C higher values were obtained. In particular, the solubility value 
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calculated at 85 bar is comparable to that measured at 100 bar at the same temperature 
(2.52·10-8 mole fraction). 
 
4.4.4 CO2 solubility in PEG 1500 by gravimetric method 
 
Results of  the determination of the solubility of CO2 in PEG 1500 at 35 an 55 °C in a 30-
250 bar pressure range are reported in Figure 58 as % w/w vs CO2 pressure.  
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Figure 58. Solubility (%w/w) of CO2 in PEG 1500 as function of CO2 pressure at 35 and 55 °C. The bars 
represent the standard deviation (n=3) 
 
The solubility data increased with the increase of pressure and temperature, but a different 
trend could be underscored. At 35 °C the solubility dramatically increased up to 100 bar, 
then it approached a plateau. At 55 °C the solubility of CO2 increased with pressure up to 
75 bar, after that value it remained almost constant up to 100 bar and then it decreased 
slightly, achieving a constant value similar to that of the plateau observed at the same 
pressure and 35 °C. 
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4.4.5 Measurement of CO2 sorption and PEG 1500 swelling by ATR-FTIR 
spectroscopy   
 
Principles 
 
Figure 59, shows, as an example, the ATR-IR spectra collected at 55 °C of pure PEG 1500 
(ambient pressure) and CO2 (125 bar). It can be observed that the IR bands relevant to CO2 
and PEG are well separated and clearly distinguishable. 
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Figure 59. ATR-IR spectra of pure PEG a 55 °C (solid line) before the exposure at the CO2 and of pure CO2 
at 55 °C and 125 bar (dashed line) 
 
Main characteristic absorption bands are 660 and 2338 cm-1 for CO2 corresponding to the 
bending and the asymmetric stretching, respectively and 1100 and 2840 cm-1 for PEG 1500. 
Although, all the characteristic bands were studied, the quantitative analysis presented in 
this work focused on the 2338 cm-1 and 1100 cm-1 band for CO2 and PEG, respectively. 
Upon exposure to CO2 the PEG spectrum changed (Figure 60). 
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Figure 60. ATR-IR spectra of PEG 1500 at 55 °C before (solid line) and upon (dashed line) exposure to CO2 
 
In particular, a decrease of the polymers characteristic absorption bands was observed (see 
arrows in Figure 60). 
The intensity of the CO2 absorption bands was proportional to the amount of carbon 
dioxide present into the cell which, in turn, depended on the applied pressure. When the 
polymeric film was placed onto the crystal, obviously, the spectrometer recorded the PEG 
spectrum as well as the bands of the CO2. Solely the CO2 dissolved in the polymer can be 
detected, owing to the fact that the beam penetration depth (ranging from sub-micrometer 
to several micrometers) was much smaller than the film thickness. As the CO2 pressure 
increased, the intensity of the 2338 cm-1 band increased (Figure 61) and, in the same time, 
the absorbance of the 1100 cm-1 band decreased due to a reduction of the polymer density 
(Figure 62). 
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Figure 61. Absorbance of the 2338 cm-1 band of CO2 in a PEG 1500 film at 35 (panel a) and 55 °C (panel b) 
in the 30-200 bar pressure range 
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Figure 62. Absorbance of 1100 cm-1 band of PEG 1500 at 35 °C (panel a) and 55 °C (panel b) upon exposure 
to CO2 in the 1-200 bar pressure range 
 
A remarkable modification of the shape of the 1100 cm-1 band at 35 °C was observed by 
raising the pressure above 30 bar. This effect is due to the solid/liquid transition of the 
polymer. In fact, at ambient pressure the PEG 1500 melts at 47 °C, while under SC-CO2 
the melting point decreases, as a function of pressure down to 28 °C (see section 4.4.1). 
Using infrared spectroscopy, specific weak intermolecular interactions between CO2 and 
polymer have been observed for several polymers (Kazarian et al., 1996, Nalawade et al., 
2006b). In these papers, it was proposed that Lewis acidity of the CO2 is responsible for 
interaction with polymers acting as Lewis’s base. 
In Figures 63 the spectral shifts of the 660 cm-1 band at 35 and 55 °C are reported. 
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Figure 63. Absorbance at 35 (panel a) and 55 °C (panel b) of the 660 cm-1 CO2 band in a PEG 1500 film in 
the 30-200 bar pressure range and of pure at 125 bar 
 
At both temperatures a pronounced (about 10 cm-1) shift of the CO2 bending mode relevant 
to the CO2 into the polymer with respect to that of the pure CO2 can be evidenced. This 
spectral shift is explained in terms of interaction between CO2 and PEG 1500. The 
presence of hydroxyl and ether groups in the PEG molecule is likely responsible for the 
weak interaction with the CO2 molecule leading the observed spectral shift to lower 
wavenumber region. The shape of the band corresponding to the bending mode the CO2 
shows evidence of a possible removal of degeneracy for the bending mode which is 
indicative of Lewis acid-base interaction as reported previously (Kazarian et al., 1996). 
 
Quantitative analysis 
 
In the ATR-FTIR technique, the beam of infrared radiation traverses a pyramidal crystal of 
relatively high refractive index and hits the crystal surface at an angle of incidence, θ, 
greater than the critical angle of the experiment (θcrit).  
 
θ crit = sin-1(ns / nc)  [24] 
 
where ns and nc are refractive index of the sample and the crystal, respectively. 
When θ  is higher than θ crit the IR beam is reflected from the internal surface of the crystal 
creating an evanescent wave projected orthogonally into the specimen positioned in 
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intimate contact with the ATR crystal. The evanescent electric field created into the sample 
undergoes an intensity exponential decay (Harrick, 1987): 
 
  Ε = Ε0 ⋅ e−z / d p   [25] 
 
where E is the electric field amplitude at a penetration distance into the sample z, E0 is the 
electric field amplitude at the interface, and dp is the penetration depth given by: 
 
  
dp = λ
2π (n12θ− n22 )
 [26] 
 
where, λ  is the wavelength of the incident beam, θ  is the incident angle, n1 and n2 are the 
refractive indexes of the ATR-IR crystal and the sample, respectively.  
The solubility of CO2 in the polymer and the swelling of the PEG was calculated from the 
intensity of the relevant absorption bands. 
To measure the solubility the Lambert-Beer law, which expresses the relation between the 
absorbance, A, the concentration, c, the beam path length, d, and the absorptivity, ε was 
used:  
 
A =  εcd   [27] 
 
For transmission measurement the beam path length is equal to the thickness of the 
specimen. When ATR-IR measurements are concerned, it is necessary to use a path length 
that would give the same absorbance in transmission as that obtained in an ATR-IR 
experiments. In ATR-IR measurement this path length is called effective thickness (de) and 
it depends on the polarization of the incident light. 
The effective thickness for p and s polarized light is defined as complex functions of the 
wavelength of the incident beam, the refractive index of the ATR crystal and the sample, 
and the incident angle. The effective penetration for non-polarized light, used in this work 
to calculate the solubility, is the arithmetical mean between the effective thickness for 
perpendicular (de┴)  and parallel (de║) polarization (Harrick, 1987): 
 
de = (de┴ + de║)/2  [28] 
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Harrick et al. presented also the equation for determining the de┴ and de║. The inputting 
data necessary for calculate these are:  diamond (ATR material) refractive index = 2.42; 
sample refractive index =1.46; angle of incidence = 43°; wavelength = 2338 cm-1. The 
amount of CO2 dissolved in the polymer was calculated with equation 27. The absorbance 
of the 2338 cm-1 band was quantified by measuring the height of the relevant peak. As 
molar absorptivity of high-pressure CO2 the value of 1.0 × 106 cm2 mol-1 was used (Maiella 
et al., 1999). The CO2 concentration was expressed as g CO2 per cm3 of non-swollen 
polymer. 
The swelling of the polymer was calculated by assuming that the absorptivity of the 1100 
cm-1 band is not affected by the concentration of the dissolved gas. In this case, owing to 
the above mentioned effect of the CO2 on the 1100 cm-1 band shape, the polymer 
concentration was determined by using the integrated absorbance, A, as defined by 
equation 29: 
 
  
A(v)dν1
ν 2∫ (v) = cde(v)ε(v)   [29] 
 
where de(v) is the optical path length calculated at 1100 cm-1 taken as the average value of 
the interval from 1000 cm-1 to 1200 cm-1; ε(v) is the integrated  absorption coefficient in 
the considered frequency range. 
 The absorbance before (A0) exposure to the gas is defined by the equation:  
 
  
A0(v)dν1
ν 2∫ (v) = c0de0(v)ε(v)  [30] 
 
where c0 and 0ed are the polymer concentration and the effective thickness, before the 
exposure to CO2 and ε(v) is the integrated absorption coefficient in the considered 
frequency range. 
In both cases the integration range was from 1000 cm-1 (v1) to 1200 cm-1 (v2).  
The swelling S was calculated by means of the following equation: 
 
  
c0
c
= V+ ΔV
V
=1+ ΔV
V
=1+ S  [31] 
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where V and ΔV are the polymer volume before and during the exposure to the gas 
respectively. 
By combining equations 29,30, and 31, the polymer degree of the swelling becomes: 
 
  
S= I
0
I
⋅ de
de
0
−1   [32] 
 
where I and I0 are the intensity of the bands defined  as 
 
  
I = Aν1
ν 2∫ (ν)dν    [33] 
 
As mentioned above, the effective thickness depends on the refractive index of the polymer. 
This last was consider negligibly affected by the polymer interaction with CO2 in 
agreement with what reported by Flichy et al. (Flichy et al., 2002) and also considering that 
all experiments but one (35 °C, 30 bar) were carried out on liquid specimens. 
The concentration of CO2 in the swollen polymer was transformed in mass percentage by 
using the following equation: 
  
%massCO2 =
c
gCO2 ⋅cm−3
c
gCO2 ⋅cm−3 +
ρpol
(1+ S)
 [34] 
 
where ρpol is the density of the polymer in standard conditions (measured with method 
described in section 3.2.2). 
 
PEG 1500 swelling and CO2 solubility  
 
As previously stated, for the calculation of the polymer swelling as well as of the solubility 
of CO2 in the polymer, the absorbances relevant to the 1100 cm-1 band before (A0) and 
upon (A) exposure to the gas were compared. At 35 °C and pressure between 1 and 30 bar 
the shape of the 1100 cm-1 band was different to that observed at higher pressures, because 
of the previously mentioned solid/liquid transition. At 35 °C, above 30 bar the solid/liquid 
transition implies a change in the 1100 cm-1 band. Furthermore, a density decrease from 
1.28 to 1.11 g/mL passing from solid to liquid PEG 1500 can be envisaged (see section 
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3.2.2). This difference in density leads to a difference in the area of the characteristic PEG 
band. For this reason, for the calculation of the swelling, the absorbance of said band at 35 
°C and 30 bar was compared with that at 35 °C and ambient pressure, taking into account 
the density of the solid PEG. In all other cases the comparison was made using the 1100 
cm-1 band at 55 °C and ambient pressure considering the density of the liquid PEG 1500. 
In Figure 64 the volume swelling % is reported as a function of CO2 pressure at 35 and 55 
°C. 
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Figure 64. Percentage of swelling (v/v) of PEG 1500 as function of CO2 pressure at 35 and 55 °C in the 1-
200 bar pressure range. Bars represent the standard deviation (n=3) 
 
The polymer swelling increased with pressure, while the temperature did not have a 
significant effect (Gourgouillon and Nunes da Ponte, 1999): the two swelling curves were 
practically superimposed. In general, the CO2 absorption has a remarkable effect on 
polymer swelling. Up to a pressure close to the CO2 critical value (70-80 bar), the polymer 
volume increased linearly with pressure; thereafter, the polymer swelling continued with 
the pressure increase but with a progressive decrease of the curve slope.  
In Figure 65 the solubility of CO2 in PEG 1500 (as mass percent) at the two studied 
temperatures is reported as a function of both pressure (panel a) and density (panel b). 
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Figure 65. Solubility (% w/w) of CO2 in PEG 1500 as function of CO2 pressure (panel a) and density (panel b) 
at 35 and 55 °C in the 1-200 bar pressure range. The bars represent the standard deviation (n=3) 
 
The reported data were calculated from the height of the 2338 cm-1 band taking into 
account the polymer swelling presented in Figure 64. At both temperatures the solubility 
dramatically increased with pressure until the CO2 critical pressure value, then, it 
approached a plateau. Significantly higher solubility was observed at the lower temperature 
in the supercritical region (p < 0.05 by Student’s t-test). This can be mainly ascribed to the 
effect of the temperature on the CO2 density as demonstrated by the fact that the solubility 
data at the two tested temperatures practically overlapped when reported versus the 
relevant CO2 density. 
 
4.4.6 Discussion on the solubility and swelling data 
 
In this section, the PEG 1500 swelling and CO2 solubility data obtained in this study are 
discuss in comparison to those reported in literature.  
In Figure 66, the swelling data at 35 and 55 °C, obtained both with the ATR-IR technique 
and by means of the visual observation with the high-pressure view cell are reported.  
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Figure 66. Swelling of the PEG 1500 at 35 and 55 °C. Data obtained both with the ATR-IR technique and by 
means of the visual observation with the high-pressure view cell 
 
It is possible to note that, up to 100 bar, the curves were practically superimposed. In this 
pressure range (0-100 bar), different methods gave the same results. Otherwise, for 
pressure above 100 bar, with the ATR-IR, the swelling increased with the pressure increase, 
while with the visual observation by view cell the polymer volume remained practically 
constant.  
In the ATR-IR measurements a thin film (1 mm or less in thikness) was used for the 
measurements, while in the visual observation the samples was composed by a powder 
contained in cylinder (6-7 mm in thickness). The sample in the ATR-IR was allowed to 
swell in three dimensions, while in the case of the cylinder sample, only the length along 
one dimension was measured. This difference can consider responsible for the discrepancy 
observed in the two cases (Hariharan et al., 1994).  
The solubility data collected at 35 °C with the high pressure view cell were compared with 
those obtained by ATR-IR (Figure 67). It was not possible to compare the data with those 
of other authors because, in literature, there is no presence of the solubility data at closest 
experimental condition with respect to those adopted in this work.  
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Figure 67. Comparison between the solubility values of CO2 in PEG 1500 at 35 °C obtained in this work both 
with ATR-IR, and the gravimetric method 
 
The data obtained by the gravimetric method were comparable with those obtained by 
ATR-IR up to the critical CO2 pressure. Thereafter, although the shape of the two curves 
was comparable, the gravimetric data were significantly higher and the plateau solubility 
value was almost double relative to ATR-IR data. The solubility data collected at 55 °C, 
obtained with both the two methods, were compared with those reported by Daneshvar et 
al. (Daneshvar et al., 1990) and Weidner et al. (Weidner et al., 1997). These authors carried 
out the CO2 solubility experiments in the closest experimental conditions with respect to 
those adopted in the present thesis (Figure 68). Daneshvar et al. measured the high-
pressure phase equilibria of PEG 1000 at 50 °C, while Weidner and co-workers carried out 
the measurements at the same temperature with PEG 1500. 
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Figure 68. Comparison between the solubility values of CO2 in PEG 1500 at 55 °C obtained in this work both 
with ATR-IR, and the gravimetric method, and the data of CO2 solubility in PEG 1500 (Weidner et al.) and 
1000 (Daneshvar et al.) at 50 °C in the 30-280 bar pressure range 
 
Curiously, these solubility data were only partially in agreement to each others. For 
pressure up to 68 bar the solubility data obtained with the two different methods are in 
agreement between them and with those reported in literature. For pressure above 68 bar, 
only Weidner’s data and our data obtained by ATR-IR spectroscopy are in agreement, 
while the data obtained by Daneshvar were significantly higher. The differences of the 
reported data might be explained considering the different experimental and analytical 
methods employed. The discrepancy between the data obtained by Weidner and Daneshvar 
were already discussed by same authors (Weidner et al., 1997, Kazarian, 2000). These 
autours underlined that the experimental procedure adopted by Daneshvar et al. 
(Daneshvar et al., 1990) was probably affected by phase equilibrium problems at pressure 
higher than 150 bar, giving rise to non homogeneous samples which contained large 
amount of CO2 as a consequence of foaming. As already stated, sampling procedure and 
time needed to reach the equilibrium are major issues in phase equilibria studies. 
Furthermore, it has to be underlined that the high-pressure spectroscopical method is an in-
situ analysis that did not require any sampling procedure; and the sample used in this 
analysis was a thin polymeric film that equilibrated in a relatively small time with CO2. 
The curve of the data obtained by the gravimetric method resulted very peculiar. The 
solubility data showed a jump of solubility between 68 and 70 bar (close to the 
supercritical region) that led the solubility value up to 82 % w/w. The solubility data at 
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high pressure resulted much higher even than the solubility data obtained by Daneshavar et 
al. 
The reported data are difficult to interpreter.  
 
4.5 PEG 1500/diazepam/CO2 system 
 
As it was described above, to prepare microparticulate drug delivery systems by PGSS 
technique, a mixture of PEG and diazepam was placed in the thermostatic chamber. Then 
after the interaction with CO2, PEG 1500 liquefied allowing the diazepam dissolution into 
the CO2/liquid PEG mixture. Finally, the solution was expanded through a nozzle.  
The knowledge of the diazepam solubility in PEG under SC-CO2 allowed to fix the right 
operative conditions to obtain a solution, where diazepam is completely dissolved in the 
liquid polymer. Consequently, the knowledge of the solubility of diazepam in PEG 1500 
under SC-CO2 at different operative conditions is a necessary prerequisite to identify the 
diazepam/PEG 1500 ratio to be loaded in the thermostatic chamber. 
 
4.5.1 Quantitative analysis 
 
The quantitative analysis in the FT-IR spectroscopy to measure the solubility of diazepam 
in PEG 1500 under SC-CO2 are performed by using the Lambert-Beer law [13].  
The characteristic C=O (ketone) stretching band (1680 cm-1) of diazepam was used for the 
quantification. However, the molar absorptivity of the diazepam in PEG under SC-CO2 is 
not known. For this reason, diazepam in PEG 1500 was quantified by comparing the 
absorbance of the sample with that of known concentration solutions, taking advantage 
from a previously established linear relationship between absorbance at 1680 cm-1 and 
diazepam concentration in PEG (%w/w). 
In Figure 69 the calibration curve of diazepam in PEG 1500 in the presence of SC-CO2 is 
presented.  
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Figure 69. Calibration curve of diazepam in PEG 1500 in the presence of SC-CO2 
 
In Figure 70, as an example, the ATR-IR spectra of pure PEG 1500 and diazepam, 
collected at 55 °C in the absence of CO2 are reported along with the spectrum relevant to 
CO2 at 55 °C and 125 bar. 
 
0
0.2
0.4
0.6
0.8
1
1.2
59089011901490179020902390269029903290
wavenumber/cm-1
A
bs
or
ba
nc
e
CO2 55 °C 125bar
PEG 55 °C
diazepam
 
Figure 70. ATR-IR spectra of pure PEG 1500 (solid line) and diazepam (dotted red line) at 55 °C without 
CO2 and CO2 at 55 °C and 125 bar (dashed black line)  
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The characteristic spectral bands at 2328 cm-1 for CO2, at 1680 cm-1 for diazepam and 
1100 cm-1 for PEG 1500 did not overlap significantly to each other and showed a 
reasonable absorbance. Thus, they were used to quantify the three components. 
In Figure 71 the variation of the intensity of the 1680 cm-1 band, relevant to the drug, at 35 
°C (panel a) 55 °C (panel b) obtained with MCT detector on the drug containing film (10 
% w/w) under CO2 is reported as a function of pressure.  
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Figure 71. The 1680 cm-1 band of the drug at 35 °C (a) and 55 °C (b) and different pressures recorded with 
the MCT detector on polymeric film containing 10 % w/w diazepam 
 
The intensity of this band decreased with the increase of the pressure at both temperatures. 
The effect of the temperature was not univocal owing to the not complete equivalence of 
the sample size.  It must be recall that the ATR system could reveal only the drug dissolved 
into the polymer, namely in intimate contact with the diamond crystal. Therefore, the 
intensity reduction can be attributed to the drug partitioning between PEG 1500 and CO2. 
This was due to the progressive dissolution of the drug into the gas phase as a consequence 
of the pressure increase. The swelling of the polymer due to the progressive absorption of 
the CO2 with the pressure increase can be considered as well to explain the observed 
phenomenon. Moreover, it must be underlined that upon degassing of the system the drug 
band intensity recovered a high value, but without reaching the original intensity, namely 
that registered  at 0 bar. In order to quantify the solubility of diazepam in SC-CO2, 
transmission NIR experiments were carried out (see section 4.6).  
 
 
 
a b
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4.5.2 Solubility data 
 
As an example in Figure 72 the images obtained at 80 bar and 35 °C from the film 
containing diazepam as solid dispersed particles (75% w/v) is presented. 
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Figure 72. ATR-IR images of a PEG 1500/diazepam thin polymeric film in presence of CO2 at 80 bar and 35 
°C. (a) Spectral band distribution of the PEG 1500 (1100 cm-1), (b) diazepam (1680 cm-1) and (c) CO2 (2328 
cm-1). The spectra were extracted from the images 
 
The images correspond to an area of ca. 820×1140 μm2, as determined in a previous study 
(Chan and Kazarian, 2003) and they are accompanied with a scale bar, which associates 
the colour of the image with the absorbance of a specific band. The band intensity 
decreases passing from red to orange, to yellow, to green, to blue, being therefore red and 
blue indicative of very high and low concentration, respectively. Thus the selected ATR-IR 
spectra from specific location inside the image can be extracted. Differently from the 
above reported ATR-IR measurements on single component (MTC detector) this system 
allowed to measure the composition at the equilibrium of multicomponent system in the 
presence of solid particles, avoiding the risk of misleading results stemming from the 
measurements of the spectrum relevant to the solid particles instead of that of the solution.  
Figure 72 (a) shows the image obtained by integrating the spectral band of PEG 1500 
(1100 cm-1). The red region represents a homogeneous area where the polymer is more 
concentrated. The spectrum extracted from each pixel of this region (panel d) showed the 
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band of the polymer at 1100 cm-1, the band of the CO2 at 2328 cm-1, and a small band of 
the diazepam at 1680 cm-1. This indicates that this sample area is manly composed by PEG 
1500 and CO2, while only a small amount of drug was dissolved into the liquid 
polymer/CO2 mixture.  
Similarly, images reported in panel (b) and (c) were obtained by integrating the spectral 
band of diazepam at 1680 cm-1, and CO2 at 2328 cm-1, respectively.  
The red region in panel b represents a diazepam particle; the corresponding area in panel c 
indicates the practical complete absence of CO2 evidently due to the fact that the CO2 did 
not solubilize into diazepam. On the other hand, the red region in panel c confirmed the 
high CO2 solubility in PEG 1500 (red region in panel a) already demonstrated with the 
analysis of CO2 solubility in PEG. Finally, it is worthy to underline that in all three images 
colour (concentration) gradient could be evidenced around the solid drug particle 
indicating that the system was not yet in equilibrium.  
The solubility of diazepam in PEG 1500 in the presence of SC-CO2 was measured from 
similar images obtained at the equilibrium. As already stated, the attainment of this last 
was verified by collecting consecutive spectra until constant intensity of the relevant band 
was achieved. Furthermore, the spectra extracted from the images, showed that in all 
regions (red, green and blue), the ratio between the height of the peaks relevant to PEG 
1500 and diazepam bands was constant, indicating the achievement of the maximum 
diazepam concentration in PEG 1500. In this situation the above mentioned drug 
concentration gradient disappeared.  
The obtained solubility values are reported in Table 11 as % w/w. 
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Table 11. Solubility value of diazepam in PEG 1500 (% w/w) as a function of temperature and pressure 
 
T 
(°C) 
P 
(bar) 
% w/w diazepam in PEG 1500 
   
35 60 10.86 
 80 10.26 
 100 9.87 
 150 9.49 
55 0 16.15 
 60 14.74 
 80 13.72 
 100 14.81 
 150 14.36 
75 0 19.10 
 60 17.95 
 100 17.95 
 150 17.95 
95 0 27.82 
 150 26.92 
 
The solubility of diazepam in the PEG 1500 increased with temperature following a 
hyperbolic trend. As far as the pressure is concerned, no significant influence was 
evidenced at fixed temperature. Quite surprisingly, at 55 and 75 °C lower diazepam 
solubility was observed compared to the value measured at ambient pressure. This kind of 
comparison could not be performed at 35 °C because at this temperature in the absence of 
CO2, PEG is solid. On the contrary, no significant difference was evidenced at 95 °C. This 
can be explained considering that the temperature increase led both to a increase of the 
diazepam solubility in PEG and to a reduction of the CO2 solvent power toward diazepam 
due to the diminution of the supercritical phase density: the overall results its an increase 
of the diazepam partitioning between PEG and CO2. 
The images at the equilibrium of all samples and experimental conditions show some 
peculiar features: they did not present a homogeneous aspect as obviously, some areas 
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pertained to solid diazepam. Beyond this, quite surprisingly the presence of round-shaped 
areas characterized by very low PEG-diazepam concentration were observed (Figure 73).  
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Figure 73. ATR-IR images of the PEG 1500 and diazepam in presence of CO2 at 80 bar and 55 °C. (a) 
spectral band distribution of PEG 1500 (1100 cm-1). (b) diazepam (1680 cm-1). Spectra extracted from images 
 
In these areas, weak CO2 band were detected. However, it must be recall that the ATR-IR 
system is able to record mainly only substances in solid or liquid state in contact with the 
crystal. When CO2 is in the gas phase, due to the different refractive index, the intensity of 
the CO2 band is smaller  than that recorded when CO2 is dissolved in the polymer phase. 
Therefore, we can speculate that these round-shaped areas area might correspond to 
supercritical CO2 bubbles entrapped into the polymeric film. This phase separation can be 
taken as an indication of the fact that in all samples at all tested conditions the PEG films 
were saturated with CO2.  
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4.6 Diazepam/CO2 system 
 
The solubility of diazepam in pure SC-CO2 are important data to estimate the potential 
drug lost into the CO2 stream during the PGSS particles formation 
 
4.6.1 Quantitative analysis 
 
The solubility of diazepam in SC-CO2 at 35 and 55 °C in the 30-180 bar range was 
measured by NIR spectroscopy in transmission. The diazepam concentration was 
determined by equation 13. The molar absorptivity coefficient (ε) of diazepam was 
measured in ethanol by assuming that the perfect overlapping of the spectra in the two 
solvents (CO2 and ethanol) indicates no change in absorptivity (Liu and Parsons, 1969).  
Linearity between drug concentration in ethanol and absorbance at 1485 cm-1 was verified 
(Figure 74). 
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Figure 74. Absorbance of diazepam solutions in ethanol as a function of diazepam concentrations (the error 
bars represent the standard deviation n=3) 
 
4.6.2 Solubility data 
 
The obtained  solubility results are reported in Figure 75 as drug concentration (mole/cm3) 
as function of both pressure (panel a) and density (panel b). 
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Figure 75. Solubility (mole/cm3) of diazepam in SC-CO2 at 35 and 55 °C as function of pressure (panel a) 
and CO2 density (panel b) 
 
The solubility of diazepam increased with pressure while it decreased with temperature, 
likely due to the CO2 density change (Kompella and Koushik, 2001). In fact, when 
represented versus CO2 density (Figure 75, panel b) the two solubility curves were 
practically superimposed. 
Interestingly, a sharp change in drug solubility was observed at 35 °C at pressure close to 
the critical value (panel a). The phenomenon was less evident at 55 °C. Again this can be 
attributed to the sudden increase in solvent density around the CO2 critical point (31.15 °C 
73.8 bar).  
 
4.7 Production of the PEG 1500 and 4000 microparticles loaded with diazepam 
 
The preformulation studies described above were employed to set-up the PGSS process. 
The ability of SC-CO2 to plasticize the polymer depends on the conditions, namely 
temperature and pressure, in the thermostatic chamber. For this reason, the knowledge of 
the phase equilibria of the PEG/CO2 system is a primary step to applied the PGSS.  
Moreover, the solubility data of CO2 in the polymer allowed to identify at which operative 
conditions the polymer is less viscous as it has been reported, the higher the solubility and 
lower the viscosity (Kukova et al., 2003). This last in turn, modifies the capacity of the 
polymer to be sprayed out through a nozzle. Furthermore, an increase in CO2 solubility in 
the polymer may lead to an increase in particles porosity. 
Furthermore, the solubility of the diazepam in the polymer in presence of SC-CO2 may 
give an indication on the possible drug loading in the particle, while the solubility of the 
drug in pure CO2 allowed to estimate the yield of the loading. 
a b 
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In this thesis, the microparticles were obtained both with PEG 1500 and 4000. The melting 
point reduction under SC-CO2 was measured for both polymers, while, only the solubility 
measurements of CO2 in the PEG 1500 were carried out. Data from literature show that the 
CO2 solubility does not change with the molecular weight of PEG, if the same physical 
state is considered (Daneshvar and Gulari, 1989b, Daneshvar et al., 1990, Gourgouillon et 
al., 1998, Lopes et al., 2000, Wiesmet et al., 2000). The measurement of the solubility of 
diazepam in PEG 4000 in the presence of CO2, was neither carried out. However, it is 
reasonable to assume that the solubility does not change with the molecular weight of the 
polymer, if the same physical state is considered.  
According to the above reported considerations, the microparticles of PEG 1500 were 
obtained at 35 and 55 °C, by charging in the thermostatic chamber diazepam/PEG binaries 
at drug concentrations around 10 % w/w at 35 °C and around 15 % w/w at 55 °C. Such 
concentrations were chosen on the basis of the temperature, because the solubility of 
diazepam in PEG in the presence of CO2 increases with temperature (Table 11).  
The pressure used was 100 and 150 bar for the experiments conducted at 35 °C while it 
was 75, 100 and 150 bar for those at 55 °C. 
The microparticles of PEG 4000 were obtained at 55 °C (at 35 °C PEG 4000 is solid at any 
pressure, Figure 54), in the 100-250 bar pressure range, and by charging in the thermostatic 
chamber a diazepam/PEG mixture containing around 15 % w/w of drug.  
 
4.7.1 Yield of the precipitation process 
 
The yield of the process is defined as the percentage of the mass of the mixture 
(PEG/diazepam) loaded in the thermostatic chamber with respect to the mass of 
microparticles obtained by PGSS.   
The obtained values of the microparticles obtained with PEG 1500 and 4000 are reported 
in the Table 12 for PEG 1500 and 4000 microparticles. 
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Table 12. Yield of the PGSS process for PEG 1500 and 4000 microparticles containing diazepam 
 
Operative conditions                     Yield 
                                          
                                         PEG 1500 
    35 °C, 100 bar                         56.5 % 
                              35 °C, 150 bar                         42.7 % 
                              55 °C, 75 bar                           29.2 % 
                              55 °C, 100 bar                         50.0 % 
                                                 55 °C, 150 bar                         63.6 % 
 
                                                     PEG 4000 
            55 °C, 100 bar                          54.4 % 
 55 °C, 150 bar                          59.5 % 
 55 °C, 200 bar                          61.3 % 
 55 °C, 250 bar                          62.2 % 
 
Reported yields varied between 29.2 and 63.6 % although all the material present into the 
autoclave was sprayed out, giving rise to a theoretical yield of 99.99%. The difference 
between the measured and theoretical yield can be ascribed to the difficulties in collecting 
particles.  
 
4.7.2 Drug content of the  microparticles 
 
The microparticles theoretical drug content (defined as the percentage by weight of 
diazepam in PEG 1500 or 4000 loaded in the thermostatic chamber, before the analysis) 
and the microparticles drug content measured by HPLC were compared (Table 13). 
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Table 13.  Measured and theoretical drug content expressed as % w/w, with the standard deviation (n=3) of 
the measured drug content  
 
 
Operative conditions     Theoretical drug content           Measured drug content               ds                      
 
PEG 1500 
35 °C, 100 bar                          9.1                                              6.8                               0.91 
35 °C, 150 bar                          9.3                                              7.1                                0.57 
55 °C, 75 bar                          12.8                                            11.1                                0.40 
55 °C, 100 bar                        12.9                                            11.3                                0.70 
55 °C, 150 bar                        13.3                                            11.7                                0.55 
  
 PEG 4000 
55 °C, 100 bar                        15.5                                            10.3                                0.18 
55 °C, 150 bar                        15.5                                            11.6                                0.38 
55 °C, 200 bar                        15.3                                            13.6                                0.73 
55 °C, 250 bar                        15.3                                            11.9                                0.60 
 
The theoretical drug content was about 3 % w/w higher then the measured one. This 
difference can be justified by considering the relatively high solubility of diazepam in the 
supercritical CO2.  
To verify the drug content uniformity three samples of the obtained microparticles were 
randomly taken and analyzed by HPLC. The mean value with the standard deviation are 
reported in Table 13. The low standard deviation (between 0.38 and 0.91) indicates a good 
uniformity of the drug content in the product, which can be expounded considering that 
particles were obtained starting from a solution.  
 
4.7.3 Particle size distributions and morphology study 
 
The particle size distributions of PEG 1500 and 4000 microparticles containing diazepam 
are reported in Table 14. 
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Table 14. Particles size distribution and standard deviation (n=3) of diazepam containing microparticles of 
PEG 1500 and 4000 
 
 
 
    Operative conditions                   dv 0.1 (μm)                   dv 0.5 (μm)               dv 0.9 (μm)    
 
PEG 1500 
35 °C, 100 bar                     12.6 ± 0.30                   53.1 ± 0.89                181.9 ± 1.9 
35 °C, 150 bar                     17.5 ± 0.25                   48.7 ± 1.21                129.6 ± 2.5 
            55 °C, 75 bar                       17.7 ± 0.18                 107.0 ± 1.90                343.8 ± 2.9 
           55 °C, 150 bar                     10.2  ± 0.25                  49.5 ± 0.65                262.8 ± 3.4 
           
            PEG 4000 
  55 °C, 100 bar                       3.9±0.07                     20.9±0.81                  46.6±3.00 
  55 °C, 150 bar                       4.1±0.16                     16.4±1.65                  40.1±6.27 
  55 °C, 200 bar                       4.3±0.29                     18.5±0.04                  42.1±1.98 
  55 °C, 250 bar                       4.4±0.06                     16.5±0.33                  35.4±2.14 
 
Furthermore, the obtained microparticles and the original PEG and diazepam materials 
were analysed by SEM to assess their morphological characteristics (Figure 76 and 77, 
respectively).  
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Figure 76. Scanning electron microscope images of PEG 1500 microparticles obtained by PGSS at different 
pressure and temperature 
 
 
       35 °C, 100 bar, 130X                                      35 °C, 100 bar, 150X MPa, 
     35 °C, 150 bar, 250X                                       35 °C, 150 bar, 5000X 
35 °C, 10 MPa, 130X                                                35 °C, 10 MPa, 150X 
35 °C, 15 MPa, 250X                                                 35 °C, 15 MPa, 5000X 
55 °C, 7.5 MPa, 130X                                                 55 °C, 7.5 MPa, 700X 
55 °C, 15 MPa, 75X                                                   55 °C, 15 MPa, 350X 
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Figure 77. Scanning electron microscope images of PEG 4000 microparticles obtained by PGSS at different 
pressure and temperature  
55 °C, 100 bar, 500X                                              55 °C, 100 bar, 3300X 
55 °C, 150 bar, 600X                                              55 °C, 150 bar, 1600X 
55 °C, 200 bar, 430X                                              55 °C, 200 bar, 850X 
55 °C, 250 bar, 130X                                              55 °C, 250 bar, 7500X 
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The microparticles of PEG 1500 show an irregular morphology with a big variation in the 
dimension (confirmed by laser light diffraction analysis), an they present different shape 
and size from the raw material (see section 4.2 and 4.3). Furthermore, these microparticles 
were made by small particles sticked together that form agglomerates difficult to separate. 
Also macroscopically the particles were sticky and difficult to handle. 
The microparticles obtained with PEG 4000 were smaller than the raw material and than 
microparticles obtained with PEG 1500. The PEG 4000 microparticles obtained at 100 bar 
were irregular and highly porous. At 150 bar the microparticles were more regular, 
agglomerate and they assumed a more regular shape. The microparticle regularity 
increased passing from 150 to 250 bar. This was accompanied by a reduction of a 
agglomeration. PEG 4000 microparticles were less sticky and more easily to handle than 
that obtained with PEG 1500.  
The morphology, as well as the particle size of the sprayed product in the PGSS technique 
are primarily determined by two phenomena: nebulization and solidification. The 
nebulization occurs when a low viscous material is sprayed trough a nozzle giving rise to a 
dispersion of very fine droplets; while the solidification occurs when the change in the 
environmental conditions make the droplets solid. The morphology as well as the particle 
size changes with the relative rate of these two processes. For example, spherical particles 
are produced when the nebulised polymer droplets have enough time to adjust their 
morphology and only after this period of time the solidification process occurs. The 
nebulization rate is determined by the flow rate of the liquefied polymer through the nozzle, 
so it can be changed by changing the viscosity of the material (the higher the pressure and 
temperature and  lower the viscosity). The solidification rate can be adjusted by changing 
the operative conditions: increase of temperature, decrease of pressure, as well as the low 
molecular mass of the polymer slow down the solidification rate. Furthermore, it has to be 
considered that if the sprayed particles cannot solidify quickly enough they might fuse 
together giving rise to agglomerates (Hao et al., 2005, Mooney et al., 1996). 
In the case of the microparticles obtained with PEG 1500, agglomerates with irregular 
shape were obtained because of the low molecular weight of the polymer. Polymer with 
low molecular weight shows a low melting point (PEG 1500 melting point is nearly 10 °C 
lower than that of  PEG 4000), and low viscosity; these characteristics generate a fast 
nebulization and slow solidification. Under these circumstances, the nebulized polymer 
solidifies slowly that the particles fuse together giving rise to the agglomerate reported in 
Figure 76.  
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As far as the temperature effect is concern, an increase of temperature decreases the 
solidification rate. Therefore, at fixed pressure higher temperature results in bigger 
particles (Table 14). On the other hand an increase in pressure gives rise a viscosity 
decrease in the polymer/diazepam solution (in the thermostatic chamber) as well as to an 
increase of the pressure drop at the nozzle. This, in turn, results in a fast solidification rate 
and nebulization result in smaller particles.   
The microparticles obtained with PEG 4000 showed lower agglomeration and particle size 
distribution, and a more regular morphology than the microparticles obtained with PEG 
1500. This higher molecular weight polymer shows a higher viscosity, and melting point 
temperature, that generates a fast microparticle solidification. Such quickly solidification 
led to the formation to less agglomerate particles. 
The higher porosity of the PEG 4000 microparticles relative to those obtained with PEG 
1500 can be ascribed to the faster solidification rate. When a fast solidification occurs, the 
CO2 remains entrapped inside the PEG/diazepam mixture affording the formation of  
micoparticles with high porosity. 
It has to be underlined that the influence of the parameters described above is quite 
complex, especially because the characteristics of the particles obtained stem from the 
combination of the effect of all above reported factors. 
 
4.7.4 Deposition study by Andersen Cascade Impactor 
 
The pulmonary deposition of the particles obtained with PEG 1500 and 4000 was carried 
out with ACI by using Turbospin® as device.  
Each batch was analyzed in triplicate. Each analysis was carried out by acting the device 
10 times through the ACI to obtain a HPLC-detectable amount of drug.  
Assuming the dose of 1 mg, the capsule of the device was loaded with nearly 10 mg of 
microparticles having a drug content ranging 10-15 % w/w.  
Although PEG 1500 particles showed non optimal characteristics for aerosolization (large 
particles with broad particle size distribution) the pulmonary deposition was tested for the 
particles obtained at 55 °C and 150 bar.  
The relevant data are reported in Figure 78. 
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PEG 1500 microparticles at 55 °C and 150bar 
 
 
Drug emitted for shot (mg)  0.75 ± 0.14 
Recovery (%)   101 ± 9.3  
MMAD (µm)   7.8 ± 1.6 
Fine particle fraction (%)  32.1 ± 0.86 
Fine particle dose (mg)  0.25 ± 0.06 
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Figure 78. Aerodynamic parameters (Table), and drug distribution % in the ACI  
 
The amount of drug emitted per shot was low and highly variable.  
Two shots were necessary to complete emission of the loaded microparticles (44.7±9.1 and 
63.2±10.6. emitted with the first and second shot, respectively).  
This behavior (pure flowability and difficult handling) reflects the tendency to stick and 
agglomerate already evidenced when discussing particle size and morphology of these 
particles.  
The aerodynamic behavior of PEG 4000 microparticles prepared at 55 °C and 100, 150, 
200, and 250 are reported in Figures 79, 80, 81 and 82, respectively.  
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PEG 4000 microparticles at 55 °C and 100 bar 
 
 
Drug emitted for shot (mg)  0.86 ± 0.06 
Recovery (%)   96.7 ± 2.81  
MMAD (µm)   8.6 ± 0.06 
Fine particle fraction (%)  24.7 ± 0.49 
Fine particle dose (mg)  0.23 ± 0.01 
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Figure 79. Aerodynamic parameters (Table), and drug distribution % in the ACI  
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PEG 4000 microparticles at 55 °C and 150 bar 
 
 
Drug emitted for shot (mg)  0.96 ± 0.02 
Recovery (%)   88.42 ± 4.34  
MMAD (µm)   7.16 ± 0.54 
Fine particle fraction (%)  29.52 ± 4.63 
Fine particle dose (mg)  0.36 ± 0.08 
0
5
10
15
20
25
30
35
40
45
50
Tr
oa
th
Sta
ge
 0
Sta
ge
 1
Sta
ge
 2
Sta
ge
 3
Sta
ge
 4
Sta
ge
 5
Sta
ge
 6
Sta
ge
 7
Fil
ter
D
ru
g 
D
ist
ri
bu
tio
n 
(%
)
 
 
Figure 80. Aerodynamic parameters (Table), and drug distribution % in the ACI  
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PEG 4000 microparticles at 55 °C and 200 bar 
 
 
Drug emitted for shot (mg)  0.91 ± 0.07 
Recovery (%)   85.30 ± 4.34  
MMAD (µm)   6.40 ± 0.77 
Fine particle fraction (%)  31.90 ± 5.80 
Fine particle dose (mg)  0.48 ± 0.09  
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Figure 81. Aerodynamic parameters (Table), and drug distribution % in the ACI  
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PEG 4000 microparticles at 55 °C and 250 bar 
 
 
Drug emitted for shot (mg)  0.99 ± 0.02 
Recovery (%)   80.95 ± 4.97  
MMAD (µm)   6.80 ± 0.36 
Fine particle fraction (%)  32.17 ± 2.23 
Fine particle dose (mg)  0.47 ± 0.05 
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Figure 82. Aerodynamic parameters (Table), and drug distribution % in the ACI  
 
All the obtained microparticles showed a better pulmonary deposition with respect to the 
raw material and the microparticles obtained with PEG 1500. The best results were 
obtained with PEG 4000 at 55 °C, 200 and 250 bar. In these cases the microparticles 
emitted with one single shot were 91 and 99 %, the mass median aerodynamic diameter 
were 6.4 and 6.8 µm, and the fine particle fraction were 31.9 and 32%, respectively. 
Interestingly, the fine particles dose was around 0.5 mg in both cases.  
Therefore, the targeted dosing (1 mg) can be achieved by two shots each one performed 
with a different capsule. 
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4.7.5 Nasal deposition 
 
To study the microparticles nasal deposition, a cast of the human nasal cavity, and a 
MIAT® insufflator were used. One shot per nostril was performed. 
The nasal deposition was calculated as the percentage of the mass of the drug deposited on 
the cast (measured by HPLC) with respect to that emitted from the device. The 
microparticles delivered were calculated as the weight difference of the device before and 
after the discharging. The obtained results are reported in Table 15. 
 
Table 15. % microparticles delivered, and % nasal drug deposition of the microparticles obtained at different 
pressures and temperatures 
 
Operative conditions          % microparticles delivered            % nasal drug deposition 
 
            PEG 1500 
35 °C, 100 bar  93.9± 1.85   27.63 ± 6.82 
35 °C, 150 bar  81.4 ± 5.3   20.85 ± 1.43 
 55 °C, 75 bar   73.4 ± 4.7    36.50 ± 11.90 
55 °C, 150 bar  91.3± 2.6   40.33 ± 2.31 
 
            PEG 4000 
55 °C, 100 bar   91.2± 10.9   20.01 ± 0.57 
35 °C, 150 bar   94.7± 2.8   24.78 ± 4.64 
55 °C, 200 bar  100 ± 0   29.70 ± 0.99 
55 °C, 250 bar  100 ± 0   21.71 ± 1.96 
 
 
As expected, the microparticles obtained with PEG 1500 showed a better nasal deposition 
relative to PEG 4000 microparticles. The trend was somewhat opposite to the trend 
observed for pulmonary deposition. This can be mainly ascribed to the effect that optimal 
nasal deposition can be obtained with particles in the 50-150 µm range (De Ascentiis et al., 
1996).   
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4.7.6 Crystallinity of the microparticles  
 
PXRD measurements were carried out to calculate the crystallinity of the embedded active 
substance. Drug crystallinity plays a key role in aqueous solubility ad stability of solid 
dosage form. 
The drug crystallinity in the microparticles was calculated on the basis of peak intensity at 
9.5 2θ and quantified by comparing the peak intensity (area) of diazepam in microparticles 
with that of a PEG/diazepam mixtures of known concentrations taking into account the 
drug content in the microparticles. The linearity between the intensity and the 
concentration of the drug in such mixture was previously checked (Figure 83 and 84).  
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Figure 83. Peak intensity of diazepam vs drug concentration in PEG 1500/diazepam binary mixture 
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Figure 84. Peak intensity of diazepam vs drug concentration in PEG 4000/diazepam binary mixture  
 
The slope of the two calibration curves were practically the same. In fact, it is reasonable 
to assume that the intensity of diazepam peak does not change with the change of the 
molecular weight of the polymer. 
The crystallinity values of the diazepam embedded in microparticles are reported in 
Table16.  
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Table 16. Crystallinity of diazepam in the PEG 1500 and 4000 microparticles obtained at different 
temperature and pressure 
 
Operative conditions                 crystallinity  (%) 
 
                                     PEG 1500 
35 °C, 100 bar                                   68.3 ± 9.8 
35 °C, 150 bar                                   100 ± 11 
55 °C, 75 bar                                     43.4 ± 8.6 
55 °C, 150 bar                                   21.2 ± 0.3 
 
                                          PEG 4000 
55 °C, 100 bar                                  56.7 ± 0.9 
55 °C, 150 bar                                  47.1 ± 5.4 
55 °C, 200 bar                                  56.9 ± 3.3 
55 °C, 250 bar                                  54.4 ± 3.8 
 
Crystallinity of embedded drug ranged between 21.2-100 %. For the PEG 1500 it is 
possible to note that the crystallinity was higher for the microparticles obtained at 35 °C 
relative to those at 55 °C. This can be ascribed to the higher solubility of diazepam in SC-
CO2 at low temperature (see section 3.2.7). If the diazepam solubility is high a drug 
partioning between polymer and SC-CO2 occurs (see section 4.5.1). When the system is 
suddenly depressurized the drug precipitates on the surface of the microparticles in form of 
microcrystal.  
 
4.7.7 Dissolution  
 
Dissolution studies of the microparticles obtained with PEG 4000 were conducted with a 
flow-through dissolution apparatus (USP 30) using distilled water at ambient temperature 
as dissolution medium. 
Pure diazepam as raw material or micronized was compared with PEG 4000 particles, 
prepared with PGSS and a physical mixture (10 % w/w) prepared with micronized PEG 
4000. The dissolution data expressed as mg of diazepam released in water as function of 
the time are reported in Figure 85.   
 
Results and Discussion  
 127
0
2
4
6
8
10
12
0 20 40 60 80 100 120
55 °C 150 bar
55 °C 100 bar
55 °C 250 bar
55 °C 200 bar
raw diazepam
micronized diazepam
Physical mixture
time (min)  
 
Figure 85. Amount of diazepam released from the microparticles (prepared at 55 °C and different pressure), 
physical mixture, raw and micronized diazepam as function of time 
 
As expected by considering the low diazepam solubility in water, the amount of drug 
dissolved in two hours from raw material was practically negligible (dissolution rate ~ 0.15 
mg/hour). No significant micronization effect could be observed. It is worthy to note that 
the dissolution profiles of the raw material (micronized and not micronized) were linear, 
indicating the achievement of the steady state. These conditions are generated when an 
active ingredient dissolves at a constant rate giving rise a solution with a constant 
concentration. Since the experiments were carried out in perfect sink conditions, the above 
reported amount of drug dissolved per unit time represent the highest dissolution rate 
achievable from pure diazepam in this conditions.  
A better dissolution rate, nearly 2 mg per hour, was obtained with the physical mixture, 
due to the solubilising effect of the PEG (Doshi et al., 1997).  
A dramatic increase of the diazepam dissolution rate was observed for all prepared 
particles. All microparticles released 60 % of the dose (10 mg) in 60 minutes and nearly 80 
% of the dose in two hours. No significant difference was observed among the 
microparticles prepared with various experimental conditions. 
The great improvement of the drug dissolution with microparticles relative to the physical 
mixture can not be samply ascribed to a difference in the particle size, in fact with the raw 
material the reduction of the particles proved to have a significant effect. Therefore, the 
observed difference should be attributed to the embedding of a drug with a reduced 
crystallinity into a highly porous particles. 
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5. Conclusions 
 
In this work a preformulation study was carried out to set-up the PGSS process which 
allowed the production of microparticulate drug delivery system.  
The phase behaviour of the binary systems PEG/CO2, diazepam/CO2 and the ternary 
system PEG/CO2/diazepam were studied to find the appropriate process conditions to 
carried out the PGSS. 
 
Both PEG 1500 swelling under pressurized CO2, and the CO2 solubility in PEG 1500 were 
measured. It was found that the polymer swells upon CO2 absorption. While the pressure 
increase determines an increase in the polymer volume, the temperature does not have a 
significant effect.  
The solubility of CO2 in PEG 1500 was influenced by both pressure and temperature; in 
general the CO2 showed a great affinity for the molten PEG. In particular, its solubility in 
the polymer remarkably increases with pressure until the CO2 critical value, then it 
approaches a plateau.  
The in situ high-pressure measurement using ATR-IR spectroscopy proved to be a 
powerful tool for measuring directly and simultaneously the degree of swelling of the 
polymer and the absorption of CO2. The depression of the melting point of the polymer 
under the action of the SC-CO2 as well as the interaction between polymer and CO2 are put 
into evidence. 
 
The melting point depression was measured both for PEG 1500 and 4000 with the high 
pressure view cell. In the 1-2 bar pressure range, the melting point of both polymers 
slightly increases, while from 2 to 87, and to 65 bar for PEG 1500 and PEG 4000, 
respectively, a decrease of melting point can be observed. Then, no further change is 
observed up to 200 bar.  
 
The PEG 1500 shows solubility in SC-CO2 in the order of 10-6 mole fraction in the 
pressure interval 100-400 bar. Isothermal solubility increases with pressure, while at fixed 
pressure it decreases with temperature, likely due to CO2 density changes. At the same 
density, temperature exhibits a positive effect on PEG 1500 solubilization in the SC gas. 
The heuristic model proposed by Giddings and co-workers proved to be a useful and 
simple tool to predict the maximum concentration achievable by the polymer in the dense 
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gas at a given temperature, as well as to quantify the polymer concentration at low 
pressures, where its experimental determination can be extremely difficult.  
 
Diazepam shows a relatively high solubility (in the order of 10-4 mole fraction at 180 bar) 
in supercritical CO2 in particular at the lower studied temperature (35 °C). 
This high solubility implies a remarkable partitioning effect between the drug dissolved 
into the polymer and in supercritical phase.  
 
The diazepam solubility in PEG 1500 under SC-CO2 varies between 10 to 27 % w/w in the 
35-95 °C temperature range. 
These figures suggest the suitability of a supercritical CO2 process for preparing 
microparticles of PEG and diazepam with adequate drug dosage.  
 
PEG plasticization by CO2 can be exploited to carry out the PGSS process. The 
measurement of the solubility of diazepam in PEG in the presence of CO2 made possible 
the production of PEG microparticles loaded with 10-15 % w/w of diazepam. 
The microparticles obtained showed a different behaviour when tested for nasal, and 
pulmonary deposition in vitro. Suitable pulmonary deposition was obtained with the PEG 
4000 microparticles due to their high porosity, low agglomeration, and small size. Better 
nasal deposition was obtained with PEG 1500 microparticles relative to PEG 4000, 
because of the greater particles dimensions of the PEG 1500 microparticles. 
Furthermore, the diazepam embedded into the microparticles shows a higher dissolution 
rate with respect to the raw, micronized material, and physical mixture.  
Finally, it ca be concluded that, from the reported data, the PGSS is a good technique for 
the production of microparticulate drug delivery systems of PEG and diazepam with 
adequate drug dosage, for administration via transmucosal or transepitelial route 
characterized by an improved drug dissolution rate and, likely, to a rapid onset of action.   
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